Canadian Journal of Cardiology

publication venue for

Differences in cardiovascular risk factors associated with biological sex, but not gender expression in young, healthy adults: a preliminary analysis. 2023
Prospective Study of Tricuspid Regurgitation Associated With Permanent Leads After Cardiac Rhythm Device Implantation 2019
A Community Health and Wellness Pilot in a Subsidised Seniors’ Apartment Building: Chap-Ems 2013
A Meta-Analysis of Randomized Controlled Trials of Everolimus-Eluting Stents Versus Bare-Metal Stents in Percutaneous Coronary Intervention 2013
A Multidisciplinary, Multimodality But Minimalist (3M) Approach to Transfemoral Transcatheter Aortic Valve Replacement Facilitates Safe Next Day Discharge in High Risk Patients 2013
Achieving Consensus About Content to Include in a Decision Aid for Implantable Defibrillator Candidates: Use of the Delphi Process 2013
Association Between Drug-Eluting Stent Type and Clinical Outcomes in Patients With and Without Renal Insufficiency Undergoing Percutaneous Coronary Intervention 2013
Clinical Significance of Left Anterior Hemiblock in Acute Coronary Syndromes 2013
Coronary Flow Reserve Pre and Post Transcatheter Aortic Valve Implantation in Severe Aortic Stenosis: An Invasive Evaluation Study of Coronary Flow Dynamics 2013
Current Use of Oral Anticoagulants Therapy in Pacemaker Patients With Pacemaker-Detected Atrial Fibrillation: Results From a Four-Nation Physician Survey 2013
Decision-Making About Goals of Care for Hospitalized Patients With Heart Failure (Decide-HF): A Pilot Study 2013
Echocardiographic Assessment of Tricuspid Valve Regurgitation Induced by Temporary or Permanent Leads in Patients Undergoing Ablation or Permanent Device Implantation 2013
Economic Evaluation of Ticagrelor Versus Clopidogrel in Canadian Patients With Acute Coronary Syndromes Based on the Platelet Inhibition and Patient Outcomes (Plato) Trial 2013
Effect of Diabetes on Atherosclerosis and Myocardial Infarction in SR-BI-/-APOE Hypomorphic Mice 2013
Efficacy and Safety of Different Bridging Regimens of Parenteral Anticoagulation After Mechanical Valve Replacement 2013
Efficacy and Safety of a Routine Pharmacoinvasive Strategy After Fibrinolysis Stratified by Glycoprotein IIB/IIIA Inhibitor Use: A Pre-Specified Subgroup Analysis of the Transfer-AMI Trial 2013
Examining the Hexosamine Biosynthetic Pathway and Its Role in the Development of Diabetes-Associated Atherosclerosis: A Metabolomic Approach 2013
IMPACT OF ADDITIONAL LEFT ATRIAL LINES ON AF RECURRENCE IN PATIENTS UNDERGOING PULMONARY VEIN ISOLATION REDO PROCEDURE 2013
Interleukin 15 Plays an Important Role in the Development of Atherosclerosis in Mice 2013
Investigating the Role of ER Stress and GSK-3 in the Osteogenic Differentiation of the Movas Cell Line 2013
Investigating the Role of Glycogen Synthase Kinase (GSK)-3α/β in Pro-Atherogenic Endoplasmic Reticulum (ER) Stress Signaling 2013
Investigating the Role of the Hexosamine Biosynthesis Pathway in Diabetic Atherosclerosis 2013
Kidney and Blood Pressure Abnormalities and Cardiac Hypertrophy, Accompany Moderate Coronary Artery Atherosclerosis in Western Diet Fed SR-BI/LDLR Double Knockout Mice 2013
Low Omega-3 Index in Erythrocytes Is a Risk Factor for Progression of Atherosclerosis in People Living With HIV 2013
One Year Survival and Predictors of Mortality in Cardiac Surgery Patients With Prolonged Intensive Care Unit Stay 2013
PULMONARY VEIN DIAMETER AND POST RADIOFREQUENCY ABLATION ATRIAL FIBRILLATION RECURRENCE: DOES SIZE MATTER? 2013
Perioperative Management of Novel Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Cardiac Rhythm Device Surgery: A Survey of Canadian Centers 2013
Pragmatic, Cluster-Randomized Controlled Trial of Delayed Educational Reminders for Long-Term Medication Adherence in St-Elevation Myocardial Infarction (Derla-Stemi) 2013
Predictors of Mortality in Patients With an Implantable Cardiac Defibrillator: A Systematic Review and Meta-Analysis 2013
Predictors of Pacemaker Dependency and Heart Failure Hospitalizations in Pacemaker Patients in the Assert Trial 2013
Prescribing Pattern of Novel Oral Anticoagulants Following Regulatory Approval for Atrial Fibrillation in Ontario, Canada 2013
Risk Prediction Models for Mortality in Ambulatory Heart Failure Patients: A Systematic Review 2013
Risk Stratification and Stroke Prevention Therapy Care Gaps in Canadian Atrial Fibrillation Patients: Insights From the Co-Ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation (Connect AF) 2013
SR-BI in Bone Marrow Derived Cells Protects Mice From Diet Induced Coronary Artery Atherosclerosis and Myocardial Infarction 2013
Safety and Efficacy of Dabigatran Compared to Warfarin for Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: a Meta-Analysis 2013
Surgical Checklist to Reduce Pacemaker and Implantable Cardioverter-Defibrillator Lead Dislodgements 2013
The Performance of Internal Medicine Residents Conducting Hand-Held Cardiac Ultrasound Examinations on Undifferentiated Cardiac Patients 2013
The Prevalence and Influence of Cardiac Prodromal Symptoms in Men and Women on Acute Coronary Syndrome (ACS) Pain Severity 2013
The Use of Interactive Internet-Based Lectures to Supplement International Cardiology Education: the Protocol for a Feasibility Study 2013
The Utility of Portable Echocardiography as a Clinical Tool in International Medicine: An Exploratory Study in Uganda 2013
Underutilization of Newer Guideline-Recommended Oral Antiplatelet Therapy: Insights From the Canadian Acute Coronary Syndrome (ACS) Reflective 2013
023 Gender Differences in the Association Between Neighbourhood Environment Characteristics With Being Overweight 2012
032 Investigating the Role of the Hexosamine Biosynthesis Pathway in Diabetic Atherosclerosis 2012
066 Active Versus Passive Fixation Atrial Leads: Incidence of Atrial Tachyarrhythmias Among Patients of the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial (ASSERT) 2012
179 Baseline Characteristics and In-Hospital Outcomes of TAVI in Ontario: Data From The Cardiac Care Network of Ontario (CCN) TAVI Registry 2012
183 Hypothermia After Out-of-Hospital Cardiac Arrest: Perspectives From Hamilton, Ontario 2012
221 Elevated CETP Activity is Associated With Low Dysfunctional HDL in South Asians 2012
247 How Do Canadian Primary Care Physicians in Family Health Teams Compare With Those in Solo-Physician Practices in Their Assessment and Management of Patients With Elevated Cardiometabolic Risk? 2012
248 Underestimation of Cardiovascular Risk in Patients With Elevated Cardiometabolic Risk in the Canadian Primary Care Setting 2012
260 Environmental Scan Of Contemporary STEMI Care In Ontario 2012
264 Barriers to EMS Utilization During STEMI 2012
268 Study of 30 Days Mortality in a Contemporary Population Of Elderly Patients Undergoing Primary Percutaneous Intervention in Acute ST Elevation MI 2012
274 Primary PCI Provincial Benchmarking: An Opportunity For Ongoing Quality Improvement 2012
279 Management and Outcomes of Non-ST Elevation Acute Coronary Syndromes in Relation to Prior Use Of Anti-Anginal Therapies 2012
283 Temporal Trends in the Management and Outcomes of ST-Segment Elevation Myocardial Infarction (STEMI) in Ontario, 2007 to 2010 2012
294 The Effectiveness Of The Acute Treatment Of Infarcting Myocardium In The Elderly - Tea Time 2012
305 Prevalence, Clinical Characteristics and Management of Coronary Chronic Total Occlusions In Current Practice: A Canadian Single Center Experience 2012
311 Transcatheter Aortic Valve Implantation (TAVI) Outcomes In Ontario 2012
322 Self-Management Training For Chronic Stable Angina 2012
341 Long-Term Statin Adherence in Secondary Prevention: A Provincial Retrospective Cohort Study 2012
418 Expression of SR-BI in Bone Marrow Derived Cells Protects Against Diet-Induced Coronary Artery Atherosclerosis in SR-BI−/−apoE-R61-Hypomorphic Mice 2012
419 Investigating the Role of Glycogen Synthase Kinase (GSK)-3 in Pro-Atherogenic Endoplasmic Reticulum (ER) Stress Signaling 2012
422 Accelerated Adipose Tissue Dysfunction and Cardiovascular Risk in Individuals of South Asian Ethnicity 2012
427 Providing a Platform for Organized Care in ST Elevation Myocardial Infarction: The LHIN-4 SMART-AMI Project in Southern Ontario Experience 2012
440 Role of Pre-Procedural Multidetector Cardiac CT Scan in Left Ventricular Lead Placement in Cardiac Resynchronization Therapy (CRT): A Pilot Study 2012
504 Subtle Differences in Commercial Heparins Can Have Serious Consequences for Cardiopulmonary Bypass Patients: a randomized controlled trial 2012
524 Scavenger Receptor Class B Type I Protects Against Doxorubicin Induced Cardiomyocyte Apoptosis 2012
570 Predictors of Radial Artery Size in Patients Undergoing Cardiac Catheterization - Insights from the Good Radial Artery Size Prediction Study (GRASP) 2012
571 Meta-Analysis Comparing Bivalirudin vs Heparin-Monotherapy on Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention 2012
582 Usefulness of Plasma B-Type Natriuretic Peptide in Predicting Outcome in Mild to Moderate Aortic Stenosis 2012
598 Multidetector Cardiac CT Scan Coronary Sinus Anatomy in Patients Undergoing CRT Device Implantation 2012
630 One-Year Adjustment to a Prophylactic Defibrillator is Influenced by Early Device Complications and Poor Mental Health 2012
643 Identifying Physician Barriers to Cardiac Rehabilitation Referral in a Tertiary Care Centre 2012
647 Evaluating Awareness and Knowledge of the Canadian Cardiovascular Society's Guidelines for the Diagnosis and Management of Heart Failure Among Residents in General Internal and Family Medicine: A Pilot Study 2012
651 Circulating Progenitor Cells and Functional Capacity in Heart Failure Patients: A Longitudinal Study 2012
652 Use of Computers and Other Technologies By Older Heart Failure Patients and Their Caregivers 2012
656 The Association Between Cognitive Function and Self-Care in Older Patients With Heart Failure 2012
692 Characterizing Intensive Care Physician Staffing Models in the Care of the Postoperative Cardiac Surgical Patient 2012
716 Leptin Promotes the Osteoblast Differentiation and Mineralization of Primary Cultures of Vascular Smooth Muscle Cells by Regulating GSK-3β 2012
721 Assessment of Aortic Plaque Inflammation and Its Relationship With Aortic Dilatation by FDG PET/CT Hybrid Imaging 2012
729 Door-To-Balloon Time as a Function of Mode of Referral: Results From the Ontario Provincial Cardiac Care Network Database 2012
750 Are Lifestyle Modifications Being Appropriately Recommended in the Canadian Primary Care Practice to Manage Elevated Cardiometabolic Risk? 2012
757 Predictors of Normal Coronary Arteries at Coronary Angiography 2012
766 Prevention of Arrhythmia Device Infection Trial (PADIT): Pilot Study Results 2012
768 Prevalence and Predictors of Sub-Clinical Atrial Fibrillation in Pacemaker Patients 2012
822 Cognitive Impairment in Older Heart Failure Patients at Hospital Discharge and its Impact on Self-Care - Results of a Prospective Study 2012
901 Importance of Risk Stratification to Explain International Variations in Results of the Coronary Trial (Off-Pump Vs. On-Pump Cabg Surgery) — the Canadian Results 2012
902 Cluster Randomized Controlled Trial to Test the Effect of Computer-Generated Individualized Audit and Feedback to Patients and Physicians on Clinical Outcomes in Atrial Fibrillation Patients Participating in a Large Multi-Center Trial of Dabigatran 2012
CIRCULATING MATRIX GLA PROTEIN AND FASTER PROGRESSION RATE OF AORTIC STENOSIS - A SUBSTUDY OF THE ASTRONOMER TRIAL 2012
COST-EFFECTIVENESS OF VENTRICULAR ASSIST DEVICE THERAPY AS A BRIDGE TO TRANSPLANT IN COMPARISON TO NON-BRIDGED CARDIAC RECIPIENTS 2012
IS ACCELERATED ATHEROSCLEROSIS A MICROVASCULAR COMPLICATION OF DIABETES? 2012
N008 New Insight Into Predictors of Self-Care Confidence in Older Patients With Heart Failure 2012
N052 The Transition From Acute Care to Home: A Review of Issues in Discharge Teaching and a Framework for Better Practice 2012
N065 Reliability of Vascular Access Site Bruise Measurement and Patient Perceptions: A Mixed Methods Study 2012
NP011 Content Validity of the Toronto Pain Management Inventory-Acute Coronary Syndrome (ACS) Version 2012
NP026 Randomized Trial of E-Learning Vs Face-to-Face Education on Patient Knowledge and Treatment Choices for Cholesterol Lowering Interventions 2012
074 Glucosamine-supplementation promotes ER stress and accelerated atherogenesis in APOE-deficient mice 2011
081 Analysis and characterization of atherosclerosis in LDLR/GSK3α double knockout mice: Examining the role of glycogen synthase kinase 3 in the progression of atherosclerosis 2011
111 Pre-operative, intra-operative and post-operative factors associated with heparin induced thrombocytopenia post cardiac surgery 2011
120 Relationship between biomarkers and intracardiac calcification in patients with mild to moderate aortic stenosis 2011
143 Comparison of transradial and femoral approaches for percutaneous coronary interventions: A hierarchical bayesian meta-analysis 2011
145 Syntax scores and real world revascularization patterns 2011
216 Variation in classification and reporting of coronary anatomy: A provincial survey 2011
236 Invasive management of patients with non-ST elevation acute coronary syndrome: Referral patterns from sites with and without catheterization facilities 2011
242 Management and outcomes of acute coronary syndrome patients with a prior history of atrial fibrillation 2011
244 Angiographic features of perioperative myocardial infarction (POMI) 2011
248 Efficacy of early invasive management post-fibrinolysis in men versus women with ST-elevation myocardial infarction: A subgroup analysis from TRANSFER-AMI 2011
331 Distribution of response to clopidogrel therapy using vasodilator stimulated phosphoprotein assay in patients undergoing primary percutaneous coronary intervention for ST segment elevation myocardial infarction 2011
405 Impact of insulin resistance on progression of left ventricular hypertrophy in patients with aortic stenosis: A substudy of the astronomer trial 2011
406 Clinical utility of transthoracic echocardiography in patients with atrial fibrillation undergoing evaluation for suspected stroke 2011
445 Discovering heart disease in first degree relatives of sudden death victims: A preliminary report from the casper registry 2011
447 Role of adrenaline infusion in evaluation of patients with unexplained cardiac arrest and familial sudden death 2011
485 Endoplasmic Reticulum stress and Glycogen Synthase Kinase-3 beta activation in apolipoprotein e-deficient mouse models of accelerated atherosclerosis 2011
486 Interleukin 15 promotes atherosclerosis in apolipoprotein E knockout mice 2011
500 Left ventricular lead position in raft - evaluating the agreement between implant and blinded post-operative chest radiograph categorization 2011
504 Does cardiac resynchronization therapy improve outcomes in patients with chronic atrial tachyarrhythmias? results from the resynchronization for ambulatory heart failure trial (raft) 2011
518 Safety and feasibility of accelerated dobutamine-atropine stress echocardiography 2011
533 Impact of clopidogrel on patients with ACS undergoing coronary bypass surgery: The practice study 2011
556 How competent are cardiology residents in interpreting ECGS? A controlled trial using an analytic framework 2011
558 The assessment of myocardial function in young and elderly syncopal patients using non-invasive impedance cardiography during tilt testing 2011
622 Aortic valve sparing root replacement 2011
638 Outcomes of primary prevention implantable cardioverter defibrillator (ICD) recipients with vs without clinical trial entry criteria: Observations from a comprehensive provincial ICD registry 2011
640 The utilisation of a remotely monitored implantable loop recorder as first line investigation in the diagnosis of syncope: The EaSyAS II study 2011
642 Failed defibrillation testing among patients having ICD replacement: Incidence, predictors and influence of selection BIAS 2011
664 Incidence and predictive factors of permanent pacemaker implantation following transcatheter aortic valve implantation with a balloon-expandable valve 2011
678 Ace inhibitor and angiotensin receptor blocker use and cardiovascular outcomes in dialysis patients: A population-based cohort study in Ontario, Canada 2011
715 Reperfusion times for radial vs. femoral access in patients with ST-elevation myocardial infarction undergoing primary PCI: Observations from the CCN provincial primary PCI registry 2011
716 Vascular access options in coronary angiogram procedures: Randomized controlled trial of a patient decision aid 2011
718 Radial versus femoral access for percutaneous coronary intervention in ST-elevation myocardial infarction patients treated with fibrinolysis: A patient-level meta-analysis of the randomized early routine invasive clinical trials 2011
720 Exploring predictors of persistent chest pain following successful percutaneous coronary intervention 2011
901 Does cardiac resynchronization therapy improve outcomes in patients with chronic atrial tachyarrhythmias? Results from the resynchronization for ambulatory heart failure trial (RAFT) 2011
N016 Cardiac pain and anxiety during acute coronary syndrome: Patient and clinician perspectives 2011
N047 Finding meaning in the message: Analysis of ICD patient education materials 2011
PREDICTIVE VALUE OF INCREASED BODY WEIGHT AND ABDOMINAL ADIPOSITY FOR CARDIOVASCULAR EVENTS IN HIGH-RISK PATIENTS A SUB-STUDY OF THE ONTARGET/TRANSCEND TRIALS 2011
A DECADE LATER THE ONTARIO SCORE IS STILL A VALID MORTALITY RISK SCORE FOR CARDIOVASCULAR SURGERY 2010
A RETROSPECTIVE STUDY OF EMBOLIC OUTCOMES FOLLOWING BIOPROSTHETIC VALVE REPLACEMENT SURGERY IN THE EARLY POSTOPERATIVE PERIOD OF PATIENTS NOT RECEIVING ROUTINE POSTOPERATIVE ANTICOAGULATION AFTER DISCHARGE 2010
BRCA1 IMPROVES ENDOTHELIAL FUNCTION AND LIMITS ATHEROSCLEROSIS 2010
CAN LEFT VENTRICULAR END-DIASTOLIC VOLUMES BE ESTIMATED WITH PROSPECTIVE ECG-GATED CT CORONARY ANGIOGRAPHY? 2010
CARBON MONOXIDE (CO) LIBERATED FROM CO-RELEASING MOLECULE (CORM) OFFERS PROTECTION AGAINST LPS-INDUCED ACTIVATION/DYSFUNCTION OF VASCULAR ENDOTHELIAL CELLS WHILE SUPPRESSING ACTIVITY OF SOD-1/-2 ENZYMES 2010
COMPARISON OF ABSTRACTED CHART REVIEW AND CORE-LAB ANGIOGRAM REVIEW ON CORONARY ANGIOGRAPHY INTERPRETATION - AN ANALYSIS FROM THE VARIATION IN REVASCULARIZATION PRACTICE IN ONTARIO ANGIOGRAPHIC SUB-STUDY 2010
DECREASE IN MATRIX GLA PROTEIN LEVEL DURING FOLLOW-UP IS ASSOCIATED WITH FASTER PROGRESSION OF AORTIC VALVE STENOSIS: A SUBSTUDY OF THE AORTIC STENOSIS PROGRESSION OBSERVATION MEASURING EFFECTS OF ROSUVASTATIN (ASTRONOMER) 2010
DETERMINANTS OF VARIATION IN REVASCULARIZATION PRACTICES IN ONTARIO (VRPO) 2010
EFFICACY AND SAFETY OF CLOPIDOGREL COMPARED WITH PLACEBO ACCORDING TO CYP2C19 GENOTYPE IN OVER 6000 PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROMES (CURE TRIAL) AND ATRIAL FIBRILLATION (ACTIVE TRIAL) 2010
EXPLORING THE DECISION-MAKING PROCESS OF PATIENTS RECEIVING ICDS FOR PRIMARY PREVENTION OF SUDDEN CARDIAC DEATH 2010
EXTERNAL VALIDATION OF THE ADDITIVE EUROSCORE: PERFORMANCE IN A FULL SPECTRUM CANADIAN CARDIOVASCULAR SURGERY COHORT 2010
FEASIBILITY OF TRANSCATHETER AORTIC VALVE IMPLANTATION IN BICUSPID AORTIC VALVE STENOSIS 2010
FIBRINOLYTIC FUNCTION IN SOUTH ASIANS AND EUROPEANS WITH CORONARY HEART DISEASE: INSIGHTS FROM THE PRACTICE REGISTRY 2010
FONDAPARINUX WITH UNFRACTIONATED HEPARIN DURING REVASCULARISATION IN ACUTE CORONARY SYNDROMES (FUTURA/OASIS 8): A RANDOMISED TRIAL EVALUATING THE SAFETY OF TWO REGIMENS OF ADJUNCTIVE INTRAVENOUS UNFRACTIONATED HEPARIN DURING PERCUTANEOUS CORONARY INTERVENTION IN HIGH-RISK PATIENTS WITH NON-ST SEGMENT ELEVATION ACUTE CORONARY SYNDROMES INITIALLY TREATED WITH SUBCUTANEOUS FONDAPARINUX 2010
GLUCOSAMINE-SUPPLEMENTATION PROMOTES ER STRESS AND ACCELERATED ATHEROGENESIS IN APOE-DEFICIENT MICE 2010
GLYCEMIC RESPONSE AFTER MAXIMAL EXERCISE STRESS TEST IS NOT AN ALTERNATIVE WAY TO SCREEN GLUCOSE INTOLERANCE AND DIABETES MELLITUS 2010
GRAFT PATENCY FOLLOWING OFF PUMP CABG VS CONVENTIONAL CABG USING 64-SLICE MDCT BYPASS GRAFT SCANNING 2010
HEART RATE IS ASSOCIATED WITH INCREASED RISK OF MAJOR CARDIOVASCULAR EVENTS, CARDIOVASCULAR AND ALL-CAUSE DEATH IN PATIENTS WITH STABLE CHRONIC CARDIOVASCULAR DISEASE - ANALYSIS OF ONTARGET/TRANSCEND 2010
IMPACT OF CLOPIDOGREL ON PATIENTS WITH ACS UNDERGOING CORONARY BYPASS SURGERY: THE PRACTICE STUDY 2010
IN-HOSPITAL LIPID TESTING AND STATIN THERAPY IN CANADIAN ACUTE CORONARY SYNDROME PATIENTS IN THE GLOBAL REGISTRY OF ACUTE CORONARY EVENTS: INCREASING OVER TIME BUT STILL UNDERUSED 2010
INCIDENCE AND PREDICTORS OF STROKE FOLLOWING CARDIAC SURGERY: THE IMPACT OF ATRIAL FIBRILLATION 2010
INITIATION OF AN INTERPROFESSIONAL INPATIENT CLINICAL PATHWAY FOR THE MANAGEMENT OF POST-OPERATIVE CARDIAC SURGERY PATIENTS WITH DIABETES: THE CARD CLINICAL PATHWAY 2010
INTERPROFESSIONAL COLLABORATION IN ACTION: A CASE-BASED PRESENTATION 2010
INVESTIGATING THE PRO-ATHEROGENIC POTENTIAL OF CHRONIC HYPERGLYCAEMIA: IS DIABETIC ATHEROSCLEROSIS A MICROVASCULAR COMPLICATION? 2010
INVESTIGATING THE ROLE OF GLYCOGEN SYNTHASE KINASE (GSK)-3 IN DIABETIC ATHEROSCLEROSIS 2010
LESSONS FROM CANRACE REGISTRY: CARE GAPS IN ACS IN CANADA: MEDICATION ADHERENCE AT HOSPITAL DISCHARGE AND AT SIX MONTHS 2010
LOSS OF PHOSPHODIESTERASE 4D ENHANCES SARCOPLASMIC RETICULUM CALCIUM RELEASE AND CARDIAC FUNCTION, INDEPENDENT OF L-TYPE CALCIUM CURRENT 2010
METABOLIC SYNDROME IS A PREDICTOR OF FASTER PROGRESSION OF AORTIC STENOSIS: A SUBSTUDY OF THE ASTRONOMER TRIAL 2010
PLASMA RENIN ACTIVITY PREDICTS CARDIOVASCULAR EVENTS AND MORTALITY IN THE HEART OUTCOMES PREVENTION EVALUATION (HOPE) STUDY 2010
PREDICTORS OF UNCERTAINTY IN CAREGIVERS OF PATIENTS WITH HEART FAILURE - A LONGITUDINAL STUDY 2010
PREVALENCE OF EARLY RHEUMATIC HEART DISEASE IN RURAL GUYANESE AMERINDIAN CHILDREN AS DETECTED BY ECHOCARDIOGRAPHIC SCREENING 2010
PREVENTION OF ARRHYTHMIA DEVICE INFECTION TRIAL (PADIT): EVIDENCE OF EQUIPOISE 2010
PULMONARY AND MUSCULAR IMPAIRMENT: CHRONIC OBSTRUCTIVE PULMONARY DISEASE VERSUS MYOCARDIAL INFARCTION OF INCREASING SEVERITY 2010
RADIAL ACCESS AS A PREDICTOR OF INCREASED RADIATION EXPOSURE DURING A DIAGNOSTIC CARDIAC CATHETERIZATION PROCEDURE 2010
RANDOMIZED TRIAL OF FONDAPARINUX VERSUS HEPARIN TO PREVENT GRAFT FAILURE AFTER CORONARY ARTERY BYPASS GRAFTING: THE FONDA CABG PILOT STUDY 2010
RATES OF DOWNSTREAM INVASIVE CORONARY ANGIOGRAPHY AND REVASCULARIZATION: COMPUTED TOMOGRAPHIC CORONARY ANGIOGRAPHY VERSUS TC-99M SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY 2010
REPERFUSION THERAPY IN STEMI: DO LATE PRESENTATION PATIENTS (=12 HOURS) DERIVE CLINICAL BENEFIT? 2010
RISK OF COMPLICATIONS AMONG ELDERLY RECIPIENTS OF PERMANENT PACEMAKERS 2010
ROSIGLITAZONE-BASED THERAPY REDUCES INFLAMMATORY BIOMARKERS IN DIABETIC, HYPERTENSIVE PATIENTS COMPARED TO A METFORMIN AND GLYBURIDE BASED-REGIMEN: THE ROSITEL RANDOMIZED TRIAL 2010
THE CANADIAN CARDIOVASCULAR SOCIETY GUIDELINES FOR THE DIAGNOSIS AND MANAGEMENT OF HEART FAILURE: RESULTS OF A 5-YEAR CLOSED LOOP IMPLEMENTATION PROGRAM 2010
THE RELATIONSHIP BETWEEN HEMOGLOBIN LEVEL AND RECURRENT ISCHEMIA IN ACUTE CORONARY SYNDROMES: INSIGHTS FROM CONTINUOUS ECG MONITORING 2010
TRANSRADIAL APPROACH FOR CORONARY ANGIOGRAPHY AND INTERVENTIONS: RESULTS OF THE FIRST INTERNATIONAL TRANSRADIAL PRACTICE SURVEY 2010
TREATMENT ASSIGNMENT OF HIGH-RISK SEVERE AORTIC STENOSIS PATIENTS REFERRED FOR TRANSCATHETER AORTIC VALVE IMPLANTATION: THE HAMILTON EXPERIENCE 2010
USE OF ASPIRATION THROMBECTOMY AND PRACTICE PATTERNS DURING PRIMARY PCI FOR STEMI - RESULTS OF A NATIONAL SURVEY 2010
UTILITY OF AN EMPIRICAL INITIAL TRIAGE RISK ASSESSMENT IN ACUTE HEART FAILURE (HF): ILLUSTRATION USING THE CANADIAN TRIAGE ACUITY SCALE 2010
VALIDATION OF THE TRUST SCORE FOR EXPOSURE TO RED BLOOD CELLS IN CARDIAC SURGERY DURING THE TOTAL LENGTH OF STAY AT HOSPITAL 2010
A molecular mechanism linking diabetes mellitus to the development of atherosclerosis 2007
A strategy of intensive glycemic control with pioglitazone does not significantly reduce instent neointimal volume after percutaneous coronary intervention in type 2 diabetic patients 2007
A systematic review of randomized trials comparing catheter-based radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation 2007
Adiponectin exhibits anti-inflammatory properties in vivo 2007
Air kerma versus fluoroscopy time as an indication of radiation dose in cardiac interventions 2007
Autonomic reflex markers in patients undergoing adenosine test for syncope of unknown origin 2007
Baseline cardiovascular risk profile of 15,889 seniors participating in C-chap trial 2007
Best independent predictor for cardiovascular events in high-risk patients: Body mass index, waist circumference or waist-to-hip ratio? (substudy of the ontarget/transcend trials) 2007
Bleeding risk of glycoprotein (GP) IIB IIIA inhibitors or thienopyridines with fondaparinux vs enoxaparin in acute coronary syndromes: Insights from the oasis 5 trial 2007
Blood pressure changes with repeated measurements using an automated BPTRU device in a pharmacy-based community-wide program 2007
Body composition methods in Canadian aboriginal adults and children in the study of health assessment and risk evaluation in aboriginal peoples action toward obesity prevention (SHARE-AP action) 2007
Characteristics and outcomes of patients not receiving reperfusion for STEMI in current practice 2007
Clinical and autonomic predictors for head-up tilt table test response in patients with suspected vasovagal syncope 2007
Clinical usefulness of tissue Doppler imaging in patients with mild to moderate aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (astronomer) study 2007
Community-based hypertension screening: A systematic review 2007
Comparison of RV strain and strain rate in patients with arrhythmogenic RV cardiomyopathy, RV outflow tract tachycardia, and matched controls 2007
Confocal microscopy of intact renal glomeruli and arterioles: A potentially novel insight into renal Ca2+ physiology 2007
Congestive heart failure assessment and management in primary care (CHAMP-C) 2007
Determinants of aortic valve calcification in aortic stenosis: Insights from the astronomer study 2007
Development of an improved strategy for perioperative bridging of anticoagulation: Predictors of wound hematoma following surgery for permanent pacemakers and implantable defibrillators 2007
Device-related infections among patients with pacemakers and implantable defibrillators: Incidence, risk factors and consequences 2007
Diabetic patients treated with primary angioplasty: Results from a metropolitan area program 2007
Donor pretreatment with hypertonic saline improves coronary artery vascular function post-cardiac transplantation 2007
Effect of aortic valve morphology on aortic valvular calcification and mitral annular calcification in patients with mild to moderate aortic stenosis 2007
Effect of homocysteine lowering B vitamins on carotid atherosclerosis: The homocysteine and atherosclerosis reduction trial (HART) 2007
Effectiveness of a trandolapril-based treatment regimen in subjects with isolated systolic hypertension - A trail subanalysis 2007
Effectiveness of optimal medical therapy in the courage trial 2007
Effectiveness of psychoeducational interventions for improving symptoms, health-related quality of life, and psychological wellbeing in patients with stable angina 2007
Effects of forced ventricular pacing in patients undergoing atrioventricular node ablation for ventricular rate control in patients with atrial fibrillation 2007
Efficacy and safety at 3 and 5 years in the canadian multi-center, randomized, double-blind trial of the sirolimus-eluting stent in the treatment of patients with de novo coronary artery lesions (C-SIRIUS) 2007
Endomyocardial expression of human leukocyte antigen-G correlates significantly with allograft tolerance in heart transplant patients 2007
Exploring the association between nutritional factors and risk of cardiovasculalr disease 2007
Glycemic control after angioplasty reduces stent restenosis in patients with diabetes: Results of the stent restenosis and metabolism (stream) study 2007
Hypoxia and reperfusion: Role of protein kinase c and enos in free radical generation 2007
Increased capacity, increased case load, decreased wait times, and decreased waitlist events: A decade of observation at a tertiary care centre in central South Ontario 2007
Interaction of calcium channel blockers and ace inhibitors therapy in heart failure patients: Data from the improving cardiovascular outcomes in nova scotia (ICONS) registry 2007
Isoform specific pkc responses modulate ET-1 and hypoxia reperfusion induced injury 2007
LV systolic and diastolic function in patients with arrhythmogenic right ventricular cardiomyopathy 2007
Measurement of the caregiving experience in caregivers of patients with heart failure: A review of current instruments and recommendations for future research 2007
Measures of vascular health: Correlation with the presence of cardiovascular risk factors 2007
Mortality and morbidity following a major bleed in a registry population with acute st elevation myocardial infarction 2007
Prevalence and gender distribution of metabolic syndrome in South Asians and white Caucasians with coronary heart disease 2007
Protein kinase C inhibitors reduce SR-BI dependent HDL lipid uptake in HepG2 cells overexpressing human SR-BI 2007
Quality of life analysis of the Canadian courage patients 2007
Recipient hypertonic saline infusion prevents primary cardiac allograft dysfunction 2007
Referrals in acute coronary events for cardiac catheterization race car study: The role of patient preference in the referral for cardiac catheterization 2007
Results from the Canadian valsartan observational hypertension study (Diovantage 4) 2007
Right and left ventricular longitudinal strain and strain rate echocardiography in a normal population 2007
Risk-benefit physician decision-making for cardiac catheterization: Insights from the race car study 2007
Surgery versus percutaneous treatment of multi-vessel coronary disease in diabetic patients: A systematic review of randomized trial sub-groups 2007
Tacrolimus preserves endothelial-dependent vasomotor function and decreases sensitivity to vasospasm 2007
The effect of duration of therapy on the benefit of fondaparinux over enoxaparin in acute coronary syndromes: Insights from the OASIS 5 trial 2007
The usefulness of routine right ventricular biopsy and incidence of significant acute cellular rejection 5 years after heart transplantation 2007
Theory to practice: Double versus triple therapy post anterior st-elevation myocardial infarction 2007
Use of automated blood pressure measurement to reduce white coat response in a pharmacy setting 2007
Evaluation of therapeutic modalities in patients with life threatening arrhythmias. 1994
The Clinical Advantages of Making Our Hospitals Older Adult Friendly.. 40:2530-2541. 2024
Ushering in a New Era of Hypertension Canada Guidelines: A Roadmap of What Lies Ahead.. S0828-282X(24)01038-9. 2024
Aging with Heart Failure: Muscle Matters.. S0828-282X(24)01013-4. 2024
ASSOCIATIONS OF BIOLOGICAL SEX WITH CARDIAC REHABILITATION UTILIZATION AND PROGRAM OUTCOMES BEFORE VS DURING THE COVID-19 PANDEMIC. 40:s132-s133. 2024
GENDER DISPARITIES IN CANADIAN INSTITUTES OF HEALTH RESEARCH GRANT FUNDING FOR CARDIOVASCULAR RESEARCH. 40:s128-s129. 2024
OUTCOMES AND PREVALENCE OF SUBCLINICAL ATRIAL FIBRILLATION IN HEART FAILURE PATIENTS. 40:s76-s77. 2024
RHYTHM VERSUS RATE CONTROL FOR PERIOPERATIVE ATRIAL FIBRILLATION AFTER NONCARDIAC SURGERY: A SYSTEMATIC REVIEW AND META-ANALYSIS. 40:s84-s85. 2024
SEX DIFFERENCES IN POST-OPERATIVE ATRIAL FIBRILLATION AFTER CARDIAC SURGERY: A RETROSPECTIVE SINGLE-CENTRE COHORT STUDY. 40:s85-s86. 2024
A Multicentre Prospective Cohort Study to Identify High-Risk Transient Ischemic Attack/Minor Stroke Patients Benefitting from Echocardiography.. S0828-282X(24)00946-2. 2024
Frailty May Blunt the Therapeutic Efficacy and Complication Risk Through Multipronged Mechanisms-REPLY.. S0828-282X(24)00927-9. 2024
Dyslipidemia and the Current State of Cardiovascular Disease: Epidemiology, Risk Factors, and Effect of Lipid Lowering. 40:S4-S12. 2024
FRAIL-AF Study: More Bleeding With DOACs Compared With VKAs in Patients With Frailty?. 40:1377-1378. 2024
Genetic Determinants of Vascular Dementia. 40:1412-1423. 2024
Colchicine and Risk of Venous Thromboembolism: A Systematic Review and Meta-analysis of Randomized Controlled Trials. 40:1344-1346. 2024
Restarting Anticoagulation After Major Bleeding in Patients With Atrial Fibrillation. 40:1291-1293. 2024
Results of the COMPASS Trial Analyzed Using Win Ratio Compared With Conventional Analytic Approaches. 40:2171-2179. 2024
Impact of Frailty on the Benefits of Dual Pathway Inhibition for the Secondary Prevention of Cardiovascular Events in the COMPASS Randomised Trial. S0828-282X(24)00506-3. 2024
Indigenizing Cardiac Rehabilitation: The Role for Cultural Adaptation. 40:1069-1076. 2024
Reply to Cheseks et al.—Expert Opinions For Refractory Cardiac Arrest: Double Sequential External Defibrillation, Vector Change, and eCPR. S0828-282X(24)00439-2. 2024
Reply to Dorian and Dorian—Risk Assessment in Immediate vs Delayed Angiography After Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation Decisions. S0828-282X(24)00504-X. 2024
Assay Precision and Risk of Misclassification at Rule-Out Cutoffs for High-Sensitivity Cardiac Troponin. 40:2102-2105. 2024
Intravascular Imaging in the Diagnosis and Management of Patients With Suspected Intracoronary Pathologies: A CJC White Paper. 40:1977-1994. 2024
Canadian Cardiovascular Society 2023 Guidelines on the Fitness to Drive. 40:500-523. 2024
Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Clinical Practice Update on Optimal Post Cardiac Arrest and Refractory Cardiac Arrest Patient Care. 40:524-539. 2024
Knowledge Translation and Systems Transformation Needed: Improving Timely and Equitable Access to Innovations in Heart Valve Disease. 40:640-642. 2024
Pulmonary Artery Catheters: Old Dog With New Tricks?. 40:674-676. 2024
What Should You Do When You Find Atrial Fibrillation on an Implanted Pacemaker or Defibrillator? It’s More Than You Think…. 40:608-609. 2024
Yes, Frailty Matters: Time for Action. 40:685-687. 2024
Are We Implanting Too Many Primary-Prevention Implantable Cardioverter-Defibrillators?. 40:1592-1595. 2024
Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology 2023 Focused Update of the Guidelines for the Use of Antiplatelet Therapy. 40:160-181. 2024
Protein and Exercise to Reverse Frailty in Older Men and Women Undergoing Transcatheter Aortic Valve Replacement: Design of the PERFORM-TAVR Trial. 40:267-274. 2024
Kawasaki Disease in the Time of COVID-19 and MIS-C: The International Kawasaki Disease Registry. 40:58-72. 2024
Adult Congenital Heart Disease Care in Canada: Has Quality of Care Improved in the Last Decade?. 40:138-147. 2023
Associations of Inflammatory Biomarkers With the Risk of Morbidity and Mortality After Cardiac Surgery: A Systematic Review and Meta-analysis. 39:1686-1694. 2023
Do Clinical Exercise Tests Permit Exercise Threshold Identification in Patients Referred to Cardiac Rehabilitation?. 39:1701-1711. 2023
A COMPREHENSIVE TRANSITIONAL CARE PROGRAM FOR HEART FAILURE PATIENTS REDUCES HOSPITAL READMISSION. 39:s57. 2023
ATRIAL FIBRILLATION RECURRENCE IN PATIENTS WITH TRANSIENT, NEW-ONSET ATRIAL FIBRILLATION DETECTED DURING HOSPITALIZATION FOR MEDICAL ILLNESS OR NON-CARDIAC SURGERY: A PROSPECTIVE, MATCHED COHORT STUDY. 39:S177-S177. 2023
Access to Heart Failure Services in Canada: Findings of the Heart and Stroke National Heart Failure Resources and Services Inventory. 39:1469-1479. 2023
IDENTIFICATION OF PAM AS NOVEL MONOGENIC DIABETES GENE. 39:S205-S206. 2023
LONG-TERM RECURRENCE OF NEW-ONSET POST-OPERATIVE AF IN CARDIAC SURGERY PATIENTS AS DETECTED BY AN IMPLANTABLE LOOP RECORDER: A SYSTEMATIC REVIEW AND INDIVIDUAL PARTICIPANT DATA META-ANALYSIS. 39:S50-S51. 2023
QTC PROLONGATION AND ITS ASSOCIATION WITH ELECTROLYTE ABNORMALITIES AND PSYCHOTROPIC DRUG USE AMONG PATIENTS WITH EATING DISORDERS. 39:S37-S38. 2023
RECURRENCE AFTER ANTICOAGULANT CESSATION IN UNPROVOKED VENOUS THROMBOEMBOLISM: IMPACT OF DEATH AS A COMPETING OUTCOME. 39:S253-S254. 2023
SAFETY AND EFFICACY OF POSTERIOR PERICARDIOTOMY AFTER CARDIAC SURGERY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. 39:S99-S99. 2023
Strategies to Reduce Transfemoral Access Complications in Contemporary Interventional Cardiology. 39:1392-1396. 2023
TECHNOLOGY-ENABLED COLLABORATIVE CARE FOR DIABETES AND MENTAL HEALTH: LEARNING FROM STUDY FINDINGS AND COMMUNITY PROVIDERS TO ACHIEVE INTEGRATED DIABETES AND MENTAL HEALTH CARE. 39:S144-S144. 2023
THE CANADIAN HEART FAILURE (CAN-HF) REGISTRY: A CANADIAN MULTI-CENTRE, RETROSPECTIVE STUDY OF OUTPATIENTS WITH HEART FAILURE. 39:s237. 2023
THE DIRECT AMPK-β1 SELECTIVE ACTIVATOR PF-06409577 TARGETS MACROPHAGES TO REDUCE ATHEROSCLEROSIS IN MICE. 39:S238-S238. 2023
Analytic Result Variation for High-Sensitivity Cardiac Troponin: Interpretation and Consequences. 39:947-951. 2023
Troponin T Levels and When to Peek Using CMR in Patients With MINOCA. 39:945-946. 2023
Cardiovascular Considerations in the Management of People With Suspected Long COVID. 39:741-753. 2023
Association Between Objectively Measured Sleep Characteristics and Cardiovascular Disease Risk in Females Aged 50+. 39:S3-S4. 2023
Development and Validation of Algorithms to Identify Transgender Women and Men in Administrative Healthcare Data: A Protocol. 39:S6-S6. 2023
Identifying Very-Low-Risk Patients for Future Myocardial Infarction or Death. 39:527-530. 2023
Neuroprognostication in the Post Cardiac Arrest Patient: A Canadian Cardiovascular Society Position Statement. 39:366-380. 2023
A Pulse Check on the Training of Adult Cardiologists in Canada: The Expanding Role of Bootcamps for Training Program Transition. 39:333-337. 2023
Alcohol Consumption and Atrial Arrhythmia Recurrence After Atrial Fibrillation Ablation: A Systematic Review and Meta-analysis. 39:266-273. 2023
High-Sensitivity Cardiac Troponin I Thresholds to Identify Myocardial Injury After Noncardiac Surgery: A Cohort Study. 39:311-318. 2023
Are Factor Xa Inhibitors Efficacious for Ischemic Stroke Prevention in Patients Without Atrial Fibrillation? Evidence From Randomized Clinical Trials. 39:187-197. 2023
Embolic Stroke of Undetermined Source: Current Perspectives on Diagnosis, Investigations, and Management. 39:172-186. 2023
Mechanisms and Clinical Manifestations of Cognitive Decline in Atrial Fibrillation Patients: Potential Implications for Preventing Dementia. 39:159-171. 2023
Reply to Saka et al.—Rhythm Control and Dementia in Patients With Atrial Fibrillation: A Role for Glymphatic System?. 39:199-199. 2023
Reply to Du et al.—Obvious Differences Between GLP1RAs and SGLT2is in the Outcomes of Heart Failure, Renal Failure, and Stroke. 39:90-90. 2023
A Call to Action: Optimizing Indigenous Cardiovascular Health in Canada. 38:1584-1587. 2022
DIETARY INTAKE AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CHRONIC VASCULAR DISEASE IN THE COMPASS TRIAL. 38:S217-S218. 2022
FACTORS INFLUENCING PATIENT DECISION AID USE FOR IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR DECISIONS IN THREE CANADIAN ACADEMIC HOSPITALS. 38:S222-S223. 2022
SURGICAL OR PERCUTANEOUS LEFT ATRIAL APPENDAGE OCCLUSION IN PATIENTS WITH ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED TRIALS. 38:S214-S215. 2022
THE STATE OF HEART FAILURE SERVICES IN CANADA: FINDINGS OF THE HEART & STROKE NATIONAL HEART FAILURE RESOURCES AND SERVICES INVENTORY. 38:S188-S189. 2022
The Evolution of Antiplatelet Therapy After Percutaneous Coronary Interventions: A 40-Year Journey. 38:S79-S88. 2022
Association of Eligibility for a Sodium-Glucose Cotransporter 2 Inhibitor and Cardiovascular Events in Patients With Atrial Fibrillation. 38:1434-1441. 2022
Management of a Left Atrial Appendage Thrombus Due to Atrial Fibrillation Complicating Québec Platelet Disorder. 38:1464-1466. 2022
Management of the Master Endurance Athlete With Stable Coronary Artery Disease. 38:1450-1453. 2022
2022 CCS/CAIC Guidelines for Training and Retraining in Adult Interventional Cardiology. 38:1307-1311. 2022
2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults. 38:1153-1167. 2022
Risk of Perioperative Stroke in Patients With Patent Foramen Ovale: A Systematic Review and Meta-analysis. 38:1189-1200. 2022
The Detection, Evaluation, and Management of Dyslipidemia in Children and Adolescents: A Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association Clinical Practice Update. 38:1168-1179. 2022
The Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists on Cardiorenal Outcomes: Systematic Review and Meta-analysis. 38:1201-1210. 2022
Reproductive Issues in Patients With the Fontan Operation. 38:921-929. 2022
Left Ventricular Noncompaction Cardiomyopathy: Left Ventricular Dilation and Dysfunction at Baseline Portend the Risk of Death or Heart Transplantation. 38:754-762. 2022
Missing the Goal With the 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. 38:705-708. 2022
Perspectives of Female Cardiology Trainees on Interventional Cardiology Training and Careers: A Canadian Nationwide Survey. 38:832-835. 2022
Antithrombotic Therapy in Peripheral Artery Disease: Risk Stratification and Clinical Decision Making. 38:654-661. 2022
Building Your Peripheral Artery Disease Toolkit: Medical Management of Peripheral Artery Disease in 2022. 38:634-644. 2022
Canadian Cardiovascular Society 2022 Guidelines for Peripheral Arterial Disease. 38:560-587. 2022
Diet and Nutrition in Peripheral Artery Disease: A Systematic Review. 38:672-680. 2022
Inflammation as a Mechanism and Therapeutic Target in Peripheral Artery Disease. 38:588-600. 2022
Peripheral Artery Disease: A High-Risk Yet Understudied, Underdiagnosed, and Undertreated Condition—A Call to Action. 38:553-554. 2022
Social Deprivation and Peripheral Artery Disease. 38:612-622. 2022
In Memoriam: George Wyse (1941-2022). 38:412-413. 2022
Return of Results Policies for Genomic Research: Current Practices and the Hearts in Rhythm Organization (HiRO) Approach. 38:526-535. 2022
Beyond Wellness Monitoring: Continuous Multiparameter Remote Automated Monitoring of Patients. 38:267-278. 2022
Digital Health: The Promise and Peril. 38:145-148. 2022
A Computed Tomography Protocol to Evaluate Coronary Artery Disease Before Transcatheter Aortic Valve Replacement. 38:23-30. 2022
Inactive Lifestyles Among Young Children With Innocent Murmurs or Congenital Heart Disease, Regardless of Disease Severity or Treatment. 38:59-67. 2022
Association of Preeclampsia With Myocardial Injury Among Patients Undergoing Noncardiac Surgery: The PREECLAMPSIA-VISION Study. 37:1934-1941. 2021
Cardiac Risk Score to Predict Small for Gestational Age Infants in Pregnant Women With Heart Disease. 37:1915-1922. 2021
The Role of National Pregnancy Surveillance Systems in Improving Maternal Mortality and Morbidity: The Next Steps for Canada. 37:1904-1907. 2021
Assessments of Heart Failure and Frailty-Related Health Instability Provide Complementary and Useful Information for Home-Care Planning and Prognosis. 37:1767-1774. 2021
Canadian Heart Rhythm Society Task Force Report on Physician Training and Maintenance of Competency for Cardiovascular Implantable Electronic Device Therapies: Executive Summary. 37:1857-1860. 2021
ANTITHROMBOTIC THERAPIES IN CANADIAN ATRIAL FIBRILLATION PATIENTS WITH CONCOMITANT CORONARY ARTERY DISEASE: INSIGHTS FROM THE CONNECT AF+PCI-I AND -II PROGRAMS. 37:S6-S7. 2021
COMPLETION OF A PHASE 2 OUTPATIENT CARDIAC REHABILITATION PROGRAM FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION OR SURGICAL AORTIC VALVE REPLACEMENT: A RETROSPECTIVE REVIEW. 37:S94-S94. 2021
EVALUATING DIRECT ORAL ANTICOAGULANTS VERSUS VITAMIN K ANTAGONISTS FOR TREATMENT OF LEFT VENTRICULAR THROMBUS: A SYSTEMATIC REVIEW AND META-ANALYSIS. 37:S11-S11. 2021
GUIDELINE-DIRECTED MEDICAL THERAPY IN A SICKKIDS PAEDIATRIC DILATED CARDIOMYOPATHY COHORT: REAL-WORLD UTILIZATION DATA. 37:S64-S64. 2021
IMPACT OF DOOR-TO-FUROSEMIDE TIME ON CLINICAL OUTCOMES IN PATIENTS WITH ACUTE HEART FAILURE. 37:S58-S59. 2021
RAFF-3 Trial: A Stepped-Wedge Cluster Randomised Trial to Improve Care of Acute Atrial Fibrillation and Flutter in the Emergency Department. 37:1569-1577. 2021
SMARTPHONE APPLICATION FOR STEMI ACTIVATION: A PILOT STUDY. 37:S8-S8. 2021
SODIUM-GLUCOSE CO-TRANSPORTER INHIBITORS AND ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. 37:S44-S45. 2021
THIAMINE VERSUS PLACEBO IN OLDER HEART FAILURE PATIENTS: A PILOT RANDOMIZED CONTROLLED CROSSOVER TRIAL (THIAMINE-HF). 37:S66-S66. 2021
The Time Has Come for Vascular Medicine in Canada. 37:1677-1677. 2021
2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults. 37:1129-1150. 2021
Accelerating Our Progress on Equity, Diversity, and Inclusion A Message From CCS President, Dr Marc Ruel. 37:1127-1128. 2021
An Approach to Investigating Discordant High-Sensitivity Cardiac Troponin I Results. 37:1292-1293. 2021
Predicting Myocardial Injury and Other Cardiac Complications After Elective Noncardiac Surgery with the Revised Cardiac Risk Index: The VISION Study. 37:1215-1224. 2021
COVID-19 Vaccination Prioritization on the Basis of Cardiovascular Risk Factors and Number Needed to Vaccinate to Prevent Death. 37:1112-1116. 2021
Balancing the Risks and Benefits of Oral Anticoagulant Use in Patients With Postoperative Atrial Fibrillation. 37:938.e11-938.e11. 2021
Cardiovascular Risk Factors and Prevention: A Perspective From Developing Countries. 37:733-743. 2021
Device-Detected Atrial Fibrillation Before and After Hospitalisation for Noncardiac Surgery or Medical Illness: Insights From ASSERT. 37:803-809. 2021
CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction. 37:531-546. 2021
Establishing a Cardiac Amyloidosis Clinic: A Practical Primer for Cardiologists. 37:674-678. 2021
Sex-Specific Differences in Heart Failure: Pathophysiology, Risk Factors, Management, and Outcomes. 37:560-571. 2021
The Optimal Timing of Primary Prevention Implantable Cardioverter-Defibrillator Referral in the Rapidly Changing Medical Landscape. 37:644-654. 2021
A National Canadian Survey of Antithrombotic Therapy After Urgent and Emergent Limb Revascularization. 37:504-507. 2021
Misclassification of Myocardial Injury by a High-Sensitivity Cardiac Troponin I Assay. 37:523.e7-523.e8. 2021
Sex, Depression, and More in Cardiac Rehabilitation. 37:357-358. 2021
Uptake of the Heart Failure Management Incentive Billing Code by Family Physicians in Ontario, Canada: A Retrospective Cohort Study. 37:508-512. 2021
An integrated mixed methods systematic review to summarize research evidence related to self-management programs for women with cardiac pain. 37:e5-e5. 2021
Exploring gender-based differences in exercise self-efficacy post-stroke: preliminary findings. 37:e8-e8. 2021
Exploring the lived experience of self-management practices of men, women and 2-spirited individuals living with type 2 diabetes in Canada, USA, Australia and New Zealand: a scoping review. 37:e8-e9. 2021
Incidence of serious fetal and neonatal events in pregnant women with heart disease. 37:e10-e11. 2021
Long-term enrollment in cardiac rehabilitation benefits cardiorespiratory fitness and skeletal muscle strength in women with cardiovascular disease. 37:e11-e11. 2021
Methodologic approaches for the development of a Canadian best practice statement for the prevention of cardiovascular diseases after a hypertensive disorder of pregnancy. 37:e12-e12. 2021
The Silent Burden of Perioperative Myocardial Infarction After Noncardiac Surgery. 37:188-190. 2021
The development and evaluation of a self-management web app for women with cardiac pain. 37:e19-e19. 2021
A Systematic Review of the Risk of Motor Vehicle Collision in Patients With Syncope. 37:151-161. 2021
Sex Disparities in the Choice of Cardiac Resynchronization Therapy Device: An Analysis of Trends, Predictors, and Outcomes. 37:86-93. 2021
Underutilization of Perioperative Screening for Cardiovascular Events After Noncardiac Surgery in Alberta. 37:57-65. 2021
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation. 36:1847-1948. 2020
Identification and Evaluation of Controlled Trials in Pediatric Cardiology: Crowdsourced Scoping Review and Creation of Accessible Searchable Database. 36:1795-1804. 2020
Immediate vs Delayed Stenting in ST-Elevation Myocardial Infarction: Rationale and Design of the International PRIMACY Bayesian Randomized Controlled Trial. 36:1805-1814. 2020
ANTIPLATELET THERAPY PRESCRIPTION PRACTICES FOR ACUTE CORONARY SYNDROME: A DECADE ANALYZED. 36:S4-S5. 2020
EFFECT OF BARIATRIC SURGERY ON NATRIURETIC PEPTIDE LEVELS: A SYSTEMATIC REVIEW AND META ANALYSIS. 36:S64-S65. 2020
EFFECTS OF LIFESTYLE INTERVENTION ON CARDIOVASCULAR DISEASE RISK IN SOUTH ASIANS: A SYSTEMATIC REVIEW AND META-ANALYSIS. 36:S90-S91. 2020
HIGH-SENSITIVITY ESTIMATE OF THE INCIDENCE OF NEW-ONSET ATRIAL FIBRILLATION IN CRITICALLY ILL PATIENTS. 36:S47-S47. 2020
IMPROVING LONG-TERM MEDICATION ADHERENCE FOR ELDERLY PATIENTS POST-MI THROUGH LONGER PRESCRIPTIONS AT INITIAL DISCHARGE: A PROCESS EVALUATION OF AN INTERVENTIONAL STUDY. 36:S11-S11. 2020
LONG-TERM SURVIVAL AFTER HEART FAILURE IN CHILDREN WITH HYPOPLASTIC LEFT HEART SYNDROME. 36:S27-S28. 2020
Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial. 36:1598-1607. 2020
Prenatal Diagnosis of Transposition of the Great Arteries Reduces Postnatal Mortality: A Population-Based Study. 36:1592-1597. 2020
SURGICAL ABLATION VERSUS CATHETER ABLATION: SYSTEMATIC REVIEW AND META-ANALYSIS. 36:S53-S53. 2020
THE SAFETY AND EFFICACY OF HIGHER COMPARED TO LOWER INTRAOPERATIVE BLOOD PRESSURE IN ADULT PATIENTS UNDERGOING CARDIAC SURGERY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. 36:S107-S108. 2020
Childhood Obesity and Cardiovascular Disease Risk: Working Toward Solutions. 36:1352-1361. 2020
Canadian Cardiovascular Society Clinical Practice Update on the Assessment and Management of Syncope. 36:1167-1177. 2020
The Prognostic Value of Intraventricular Conduction Disturbances: A Matter of Time?. 36:1196-1198. 2020
Assessing Cardiac Risk in Pregnant Women With Heart Disease: How Risk Scores Are Created and Their Role in Clinical Practice. 36:1011-1021. 2020
Caution When Using High-Sensitivity Cardiac Troponin I Assay to Rule Out Acute Ischemia: When the Delta to Rule In Is Within Analytical Variation. 36:1161.e11-1161.e12. 2020
Optimizing Access to Heart Failure Care in Canada During the COVID-19 Pandemic. 36:1148-1151. 2020
Ramping Up the Delivery of Cardiac Surgery During the COVID-19 Pandemic: A Guidance Statement From the Canadian Society of Cardiac Surgeons. 36:1139-1143. 2020
Cardiac Surgery in Canada During the COVID-19 Pandemic: A Guidance Statement From the Canadian Society of Cardiac Surgeons. 36:952-955. 2020
Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society. 36:948-951. 2020
Hypertension Canada’s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children. 36:596-624. 2020
Precautions and Procedures for Coronary and Structural Cardiac Interventions During the COVID-19 Pandemic: Guidance from Canadian Association of Interventional Cardiology. 36:780-783. 2020
Shared Decision-Making for Anticoagulation in Atrial Fibrillation: Do Physicians Really Listen?. 36:459-461. 2020
Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance. 36:357-372. 2020
CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis. 36:159-169. 2020
Role of Cardiac Auscultation in the Era of Portable Handheld Ultrasound. 36:147-150. 2020
Therapies for Advanced Heart Failure Patients Ineligible for Heart Transplantation: Beyond Pharmacotherapy. 36:234-243. 2020
Performance of Prognostic Risk Scores in Heart Failure Patients: Do Sex Differences Exist?. 36:45-53. 2020
Physician Judgement vs Model-Predicted Prognosis in Patients With Heart Failure. 36:84-91. 2020
The Role of Physicians in the Era of Big Data. 36:19-21. 2020
Analytical Variation and Abbott Diagnostics High-Sensitivity Cardiac Troponin I Risk Categories in Asymptomatic Individuals. 35:1605.e7-1605.e8. 2019
Antithrombotic Management After Transcatheter Aortic Valve Replacement: A Survey of Canadian Physicians. 35:1596-1599. 2019
A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS EVALUATING IVABRADINE IN HEART FAILURE. 35:S180-S180. 2019
A SYSTEMS APPROACH TO INTEGRATING HEART FAILURE CARE: A ‘HOW TO’ ROAD MAP BASED ON LIVED EXPERIENCE. 35:S25-S26. 2019
ASSESSING THE QUALITY OF CARE FOR PATIENTS HOSPITALIZED WITH ATRIAL FIBRILLATION/ATRIAL FLUTTER IN CANADA. 35:S18-S19. 2019
BARIATRIC SURGERY IN MORBIDLY OBESE PATIENTS WITH END STAGE HEART FAILURE AS A BRIDGE TO HEART TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS. 35:S14-S15. 2019
CARDIOVASCULAR RISK FACTORS IN SOCIAL HOUSING RESIDENTS: A MULTI-SITE DESCRIPTIVE SURVEY IN OLDER ADULTS FROM ONTARIO, CANADA. 35:S86-S86. 2019
CONNECTING CARE TO HOME FOR HEART FAILURE PATIENTS: AN EFFECTIVE STRATEGY TO REDUCE HOSPITAL READMISSION RATES. 35:S201-S202. 2019
DOES A HEART TEAM ACTUALLY IMPROVE CLINICAL OUTCOMES?. 35:S75-S75. 2019
LEFT VENTRICLE EFFICIENCY IN CHILDREN WITH MODERATE AORTIC VALVE REGURGITATION OR MODERATE AORTIC VALVE STENOSIS. 35:S116-S116. 2019
Long-term Enrollment in Cardiac Rehabilitation Benefits Cardiorespiratory Fitness and Skeletal Muscle Strength in Men With Cardiovascular Disease. 35:1359-1365. 2019
Making the Cut: Perspectives on the Surgical Management of Infective Endocarditis Among People Who Use Intravenous Drugs. 35:1416-1418. 2019
NATRIURETIC PEPTIDES AS PREDICTORS OF MORTALITY IN ADULT AMBULATORY HEART FAILURE PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. 35:S41-S42. 2019
ON VENTRICLE PUMPING EFFICIENCY IN MIXED AORTIC VALVE DISEASE AND A NEED FOR NEW PARAMETERS. 35:S38-S39. 2019
OUTCOMES OF AN ATRIAL FIBRILLATION PATIENT NAVIGATION DEMONSTRATION PROJECT. 35:S62-S63. 2019
Outcomes Among Clopidogrel, Prasugrel, and Ticagrelor in ST-Elevation Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention From the TOTAL Trial. 35:1377-1385. 2019
PRE- AND POST-TREATMENT WITH ANTIARRHYTHMIC DRUGS FOR ELECTRICAL CARDIOVERSION OF ATRIAL FIBRILLATION: A NETWORK META-ANALYSIS. 35:S150-S150. 2019
PREDICTING MORTALITY AND HOSPITALIZATION IN CHRONIC HEART FAILURE PATIENTS WITH ISCHEMIC CARDIOMYOPATHY. 35:S111-S112. 2019
PRESCRIPTION OF ORAL ANTICOAGULATION IN PATIENTS WITH A PRIMARY OR SECONDARY DIAGNOSIS OF ATRIAL FIBRILLATION WHO ATTEND THE EMERGENCY DEPARTMENT. 35:S187-S188. 2019
RESTING HEART RATE AS A PREDICTOR OF MORTALITY IN PATIENTS WITH HEART FAILURE. 35:S61-S61. 2019
Risk of Hospital Admissions in Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis. 35:1332-1343. 2019
SURGICAL ABLATION OF ATRIAL FIBRILLATION EVALUATION (SAFE): A COST ANALYSIS. 35:S143-S143. 2019
THE EFFECT OF A FORMALIZED DISCHARGE PROCESS WHICH INCLUDES ELECTRONIC DELIVERY OF PRESCRIPTIONS TO PHARMACIES ON THE INCIDENCE OF DELAYED PRESCRIPTION RETRIEVAL AMONG PATIENTS DISCHARGED FROM CARDIAC INPATIENT CARE. 35:S96-S96. 2019
THE FRAIL-D STUDY: IMPLICATIONS OF THE FRAILTY PHENOTYPE IN PATIENTS UNDERGOING PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS. 35:S73-S73. 2019
THE HEART OUTCOMES PREVENTION EVALUATION 4 CANADA: A PILOT STUDY OF A COMMUNITY-BASED, MULTI-FACETED INTERVENTION, LED BY NON-PHYSICIANS TO REDUCE CARDIOVASCULAR RISK IN PEOPLE WITH HYPERTENSION. 35:S22-S23. 2019
WALL THICKNESS NORMALIZATION IN PEDIATRIC HYPERTROPHIC CARDIOMYOPATHY: CHARACTERIZING PREDICTORS AND PATIENT OUTCOMES. 35:S152-S152. 2019
Antiplatelet Therapy and Coronary Artery Bypass Grafting: Analysis of Current Evidence With a Focus on Acute Coronary Syndrome. 35:1030-1038. 2019
Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in Atrial Fibrillation (BRAIN-AF): Methods and Design. 35:1069-1077. 2019
Screening for Atrial Fibrillation Using a Mobile, Single-Lead Electrocardiogram in Canadian Primary Care Clinics. 35:840-845. 2019
Four Different High-Sensitivity Cardiac Troponin Assays With Important Analytical Performance Differences. 35:796.e17-796.e18. 2019
Statin Use in Primary Prevention: A Simple Trial-Based Approach Compared With Guideline-Recommended Risk Algorithms for Selection of Eligible Patients. 35:644-652. 2019
Longitudinal High-Sensitivity Cardiac Troponin I Measurements in Patients With Breast Cancer Receiving Trastuzumab. 35:545.e1-545.e2. 2019
Reversible Cabozantinib-Induced Cardiomyopathy. 35:544.e1-544.e2. 2019
2019 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Guidelines on the Acute Management of ST-Elevation Myocardial Infarction: Focused Update on Regionalization and Reperfusion. 35:107-132. 2019
Association Between Patient and Physician Sex and Physician-Estimated Stroke and Bleeding Risks in Atrial Fibrillation. 35:160-168. 2019
Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018. 34:1553-1563. 2018
The Association of Kidney Function and Albuminuria With the Risk and Outcomes of Syncope: A Population-Based Cohort Study. 34:1631-1640. 2018
2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation. 34:1371-1392. 2018
Is Screening for Atrial Fibrillation in Canadian Family Practices Cost-Effective in Patients 65 Years and Older?. 34:1522-1525. 2018
The Guideline-Policy Gap in Direct-Acting Oral Anticoagulants Usage in Atrial Fibrillation: Evidence, Practice, and Public Policy Considerations. 34:1412-1425. 2018
ANTIPLATELET AND ANTICOAGULATION THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION AND CORONARY ARTERY DISEASE: A SURVEY OF CANADIAN PHYSICIANS. 34:S104-S105. 2018
ASSESSING THE FEASIBILITY OF DELIVERING A PRE-IMPLANTATION NURSE-LED EDUCATIONAL INTERVENTION TO PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER DEFIBRILLATOR CANDIDATES: A RANDOMIZED FEASIBILITY TRIAL. 34:S207-S207. 2018
BENZODIAZEPINE-FREE CARDIAC ANESTHESIA FOR REDUCTION OF DELIRIUM (B-FREE): A TWO-CENTRE PILOT STUDY TO DETERMINE THE FEASIBILITY OF A MULTI-CENTRE, RANDOMIZED, CLUSTER CROSSOVER TRIAL. 34:S72-S73. 2018
CARDIAC RESYNCHRONIZATION IS PRO-ARRHYTHMIC IN THE ABSENCE OF REVERSE VENTRICULAR REMODELLING: A SYSTEMATIC REVIEW AND META-ANALYSIS. 34:S134-S135. 2018
CONCOMITANT CARDIAC RESYNCHRONIZATION THERAPY IN PATIENTS UNDERGOING CARDIAC SURGERY: A SYSTEMATIC REVIEW AND META-ANALYSIS. 34:S60-S60. 2018
CONTEMPORARY ANTIPLATELET THERAPY IN MODERATE TO HIGH-RISK PATIENTS WITH NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE CANADIAN ACS REFLECTIVE II STUDY. 34:S11-S12. 2018
CONTEMPORARY USE OF ORAL ANTITHROMBOTIC THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE CONNECT AF+PCI STUDY. 34:S16-S16. 2018
CardioDiabetes: Core Competencies for Cardiovascular Clinicians in a Rapidly Evolving Era of Type 2 Diabetes Management. 34:1350-1361. 2018
DEVELOPMENT OF A PATIENT DECISION AID FOR PATIENTS WHO ARE HIGH RISK CANDIDATES FOR CORONARY ARTERY BYPASS SURGERY. 34:S63-S64. 2018
ENGAGING PATIENT PARTNERS TO IDENTIFY ATRIAL FIBRILLATION RESEARCH PRIORITIES-RESULTS FROM A PATIENT ENGAGEMENT WORKSHOP. 34:S201-S201. 2018
GENOMIC ARCHITECTURE OF TETRALOGY OF FALLOT AND GENOMIC PREDICTORS OF ADVERSE RIGHT VENTRICULAR REMODELLING. 34:S57-S57. 2018
Histoplasma Endocarditis Diagnosed by Thrombus Aspiration. 34:1370.e9-1370.e11. 2018
IMPORTANT FOOD SOURCES OF FRUCTOSE-CONTAINING SUGARS AND CARDIOVASCULAR OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS OF PROSPECTIVE COHORT STUDIES. 34:S25-S26. 2018
LONG-TERM MEMBERSHIP IN CARDIAC REHABILITATION PRESERVES CARDIORESPIRATORY FITNESS AND MUSCLE STRENGTH IN MEN WITH CARDIOVASCULAR DISEASE: A RETROSPECTIVE REVIEW. 34:S39-S40. 2018
LONG-TERM RISK OF STROKE AFTER AN EPISODE OF ATRIAL FIBRILLATION OCCURRING TRANSIENTLY WITH STRESS FOLLOWING NON-CARDIAC SURGERY: A SYSTEMATIC REVIEW AND META-ANALYSIS. 34:S133-S134. 2018
NON-VKA ORAL ANTICOAGULANTS VERSUS VITAMIN K ANTAGONISTS IN PATIENTS UNDERGOING CARDIOVERSION FOR ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS. 34:S186-S186. 2018
PRE-TREATMENT WITH AMIODARONE FOR ELECTIVE ELECTRICAL CARDIOVERSION OF ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS. 34:S153-S154. 2018
RIGHT VENTRICULAR PACING IS ASSOCIATED WITH INCREASED RATES OF APPROPRIATE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SHOCKS. 34:S42-S43. 2018
THE ASSOCIATION BETWEEN IMMIGRATION AND ETHNICITY ON ADHERENCE TO STATINS AND CARDIAC REHABILITATION POST-MYOCARDIAL INFARCTION. 34:S39-S39. 2018
Application of Syncope Guidelines in the Emergency Department Do Not Reduce Admission Rates: A Retrospective Cohort Study. 34:1158-1164. 2018
Establishing Therapeutic Equivalence of Complex Pharmaceuticals: The Case of Dabigatran. 34:1116-1119. 2018
Patterns of Care During the Terminal Hospital Admission for Patients With Advanced Heart Failure: A Retrospective Cohort Study. 34:1215-1218. 2018
The Future of Electrocardiogram Interpretation Teaching in the Digital Age. 34:1091-1093. 2018
Cardiac Complications Associated With Checkpoint Inhibition: A Systematic Review of the Literature in an Important Emerging Area. 34:1059-1068. 2018
Heart Failure Management in Nursing Homes: A Scoping Literature Review. 34:871-880. 2018
Postoperative Remote Automated Monitoring: Need for and State of the Science. 34:850-862. 2018
The Spoke-Hub-and-Node Model of Integrated Heart Failure Care. 34:863-870. 2018
“NEW” Prehabilitation: A 3-Way Approach to Improve Postoperative Survival and Health-Related Quality of Life in Cardiac Surgery Patients. 34:839-849. 2018
Canadian Guidelines Need Synchronized Efforts With Rigorous and Transparent Methodology. 34:813.e1-813.e1. 2018
Canadian Registry of Implantable Electronic Device Outcomes: Surveillance of High-Voltage Leads. 34:808-811. 2018
Incident Atrial Fibrillation and Stroke in Patients With Atrial Flutter. 34:696-697. 2018
Long-term Follow-up of the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI). 34:736-743. 2018
Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. 34:506-525. 2018
The Genetic Link Between Diabetes and Atherosclerosis. 34:565-574. 2018
Assessing the Consistency and Quality of the Evidence for the Association Between Dietary Factors and Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of Prospective Cohort Studies and Randomized Controlled Trials. 34:e20-e20. 2018
Cardiovascular Disease Among Women From Vulnerable Populations: A Review. 34:450-457. 2018
Diet, Pre-eclampsia and Gestational Hypertension: A Systematic Review and Meta-Analysis of Prospective Cohort Studies and Randomized Controlled Trials. 34:e20-e20. 2018
Self-Management Interventions for Women With Cardiac Pain: A Systematic Review and Meta-analysis. 34:458-467. 2018
The Association Between Time in Canada and Diet Quality in South Asian Immigrants: A Study of Pregnant Women. 34:e5-e6. 2018
The Self-Management of Cardiac Pain in Women with Coronary Artery Disease: A Systematic Review and Meta-Analysis. 34:e12-e12. 2018
Understanding Barriers and Facilitators to Changing Diet and Physical Activity Patterns in South Asian Women at Risk of Gestational Diabetes Mellitus: A Pilot Qualitative Study (DESI-GDM Q). 34:e17-e18. 2018
Women and Peripheral Arterial Disease: A Review of Sex Differences in Epidemiology, Clinical Manifestations, and Outcomes. 34:356-361. 2018
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy. 34:214-233. 2018
Design of a Randomized Placebo-Controlled Trial to Assess Dabigatran and Omeprazole in Patients with Myocardial Injury after Noncardiac Surgery (MANAGE). 34:295-302. 2018
Epidemiology of Kawasaki Disease in Canada 2004 to 2014: Comparison of Surveillance Using Administrative Data vs Periodic Medical Record Review. 34:303-309. 2018
Frailty, the Elderly, and the Guidelines on Perioperative Cardiac Risk Assessment and Management in Noncardiac Surgery. 34:343.e13-343.e13. 2018
Management of Non-ST-Elevation Myocardial Infarction in Elderly Patients: Time to Consider Frailty and Quality of Life. 34:241-243. 2018
Contemporary Emergency Department Management of Patients with Chest Pain: A Concise Review and Guide for the High-Sensitivity Troponin Era. 34:98-108. 2018
Does Early Coronary Angiography Improve Survival After out-of-Hospital Cardiac Arrest? A Systematic Review With Meta-Analysis. 34:180-194. 2018
Variability Between Reagent Lots for High-Sensitivity Cardiac Troponin I May Affect Performance of Early Rule Out Strategies. 34:209.e5-209.e6. 2018
Avoiding Clinical Errors With Bedside Echocardiography: A Randomized Clinical Study. 34:88-91. 2018
Long-term Effects of Statins, Blood Pressure-Lowering, and Both on Erectile Function in Persons at Intermediate Risk for Cardiovascular Disease: A Substudy of the Heart Outcomes Prevention Evaluation-3 (HOPE-3) Randomized Controlled Trial. 34:38-44. 2018
A Case of Spontaneous Coronary Artery Dissection Complicated by Free Wall Rupture. 33:1736.e13-1736.e15. 2017
Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults (vol 33, pg 557, 2017). 33:1733-1734. 2017
2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure. 33:1342-1433. 2017
Canadian Women in Cardiovascular Medicine and Science: Moving Toward Parity. 33:1339-1341. 2017
Heart Failure in Transition: Is It Really Better to Be Younger?. 33:1455-1456. 2017
Impact of Injectable Furosemide Hospital Shortage on Congestive Heart Failure Outcomes: A Time Series Analysis. 33:1498-1504. 2017
The Need for Heart Failure Advocacy in Canada. 33:1450-1454. 2017
ACTIONABLE ATRIAL FIBRILLATION: WHEN DO I GET MY OAC?. 33:S61-S61. 2017
Association of Apolipoproteins B and A-1 With Markers of Vascular Health or Cardiovascular Events. 33:1305-1311. 2017
COMPARISON OF HEALTH RELATED QUALITY OF LIFE IN ATRIAL FIBRILLATION PATIENTS TREATED WITH CATHETER ABLATION OR ANTIARRHYTHMIC DRUG THERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS. 33:S57-S57. 2017
COST EFFECTIVENESS OF VENTRICULAR TACHYCARDIA ABLATION VERSUS ESCALATION OF ANTIARRHYTHMIC DRUG THERAPY IN THE VANISH TRIAL. 33:S16-S17. 2017
DEVELOPMENT OF KEY HEART FAILURE CLINICAL INDICATORS FOR A COMMUNITY ELECTRONIC MEDICAL RECORD. 33:S220-S220. 2017
GAPS IN PRESCRIBING TICAGRELOR OVER CLOPIDOGREL FOR PATIENTS WITH ACUTE CORONARY SYNDROME AT TWO ACADEMIC HOSPITALS. 33:S127-S128. 2017
HEART FAILURE GUIDELINES APPLIED IN PRACTICE (HF-GAP) TOOLKIT REVISION 2016. 33:S219-S219. 2017
HEART FAILURE OUTCOMES AND PREDICTORS OF SUBCLINICAL ATRIAL FIBRILLATION PROGRESSION. 33:S196-S196. 2017
Multidisciplinary Heart Failure Clinics Are Associated With Lower Heart Failure Hospitalization and Mortality: Systematic Review and Meta-analysis. 33:1237-1244. 2017
OPTIMAL USAGE OF SACUBITRIL/VALSARTAN FOR HEART FAILURE TREATMENT IN CANADA POTENTIALLY REDUCES HOSPITALIZATIONS AND EARLY DISCHARGE RE-ADMISSIONS. 33:S161-S161. 2017
PREDICTORS OF COGNITIVE DECLINE AFTER CARDIAC SURGERY: AN EVALUATION OF THE CABG OFF OR ON PUMP REVASCULARIZATION STUDY (CORONARY) COHORT. 33:S36-S36. 2017
THE FRAIL-D STUDY: ASSESSING FRAILTY AS A RISK FACTOR FOR OUTCOMES IN PATIENTS WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATORS FOR PRIMARY PREVENTION. 33:S154-S154. 2017
THE PROTROPIC FEASIBILITY STUDY: PROGNOSTIC VALUE OF ELEVATED TROPONINS IN CRITICAL ILLNESS. 33:S56-S56. 2017
THE ROSS PROCEDURE: A SYSTEMATIC REVIEW AND META-ANALYSIS. 33:S85-S86. 2017
Utility of Unfractionated Heparin in Transradial Cardiac Catheterization: A Systematic Review and Meta-analysis. 33:1245-1253. 2017
VASOPRESSIN VERSUS CATECHOLAMINERGIC VASOPRESSORS IN THE TREATMENT OF VASODILATORY SHOCK: A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE IMPACT ON ATRIAL FIBRILLATION, MYOCARDIAL INJURY AND MORTALITY. 33:S129-S130. 2017
Adult Congenital Heart Disease Intervention: The Canadian Landscape. 33:1201-1205. 2017
Structural Heart Disease Intervention: The Canadian Landscape. 33:1197-1200. 2017
Comparative Evaluation of 2-Hour Rapid Diagnostic Algorithms for Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin T. 33:1006-1012. 2017
Long-term Follow-up of the Implementation of a Venous Thromboembolism Prophylaxis Order Set on a Cardiology Ward: Still a Surprising Result?. 33:1067.e1-1067.e1. 2017
Rationale, Design and Baseline Characteristics of Participants in the C ardiovascular O utco m es for P eople Using A nticoagulation S trategie s (COMPASS) Trial. 33:1027-1035. 2017
A Practical Guide to the Use of Glucose-Lowering Agents With Cardiovascular Benefit or Proven Safety. 33:940-942. 2017
High-Sensitivity Cardiac Troponin Risk Cutoffs for Acute Cardiac Outcomes at Emergency Department Presentation. 33:898-903. 2017
Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis. 33:737-746. 2017
Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. 33:557-576. 2017
Diabetes for Cardiologists: Practical Issues in Diagnosis and Management. 33:366-377. 2017
Effective Management of Cardiovascular Risk Factors—Are We Doing Enough?. 33:300-302. 2017
Macrophage Apoptosis and Necrotic Core Development in Atherosclerosis: A Rapidly Advancing Field with Clinical Relevance to Imaging and Therapy. 33:303-312. 2017
The Emerging Epidemic of Cardiovascular Risk Factors and Atherosclerotic Disease in Developing Countries. 33:358-365. 2017
Associations Between Childhood Cognition and Cardiovascular Events in Adulthood: A Systematic Review and Meta-analysis. 33:232-242. 2017
Effect of Mobile Health Interventions on the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis. 33:219-231. 2017
Which Patients With Atrial Fibrillation and Chronic Kidney Disease Should Receive Anticoagulation—And With Which Anticoagulant?. 33:211-213. 2017
Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery. 33:17-32. 2017
Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Position Statement on the Optimal Care of the Postarrest Patient. 33:1-16. 2017
The Routine Use of the Pulmonary Artery Catheter Should Be Abandoned. 33:135-141. 2017
At What Age Does Stroke Risk Increase in Patients With Atrial Fibrillation? Does It Depend on Where You Live?. 32:1364-1365. 2016
Identifying Patients With Atrial Fibrillation in Administrative Data. 32:1561-1565. 2016
Impact of a Genetic Risk Score on Myocardial Infarction Risk Across Different Ethnic Populations. 32:1440-1446. 2016
The Canadian Arrhythmogenic Right Ventricular Cardiomyopathy Registry: Rationale, Design, and Preliminary Recruitment. 32:1396-1401. 2016
The Development and Feasibility Assessment of Canadian Quality Indicators for Atrial Fibrillation. 32:1566-1569. 2016
2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. 32:1263-1282. 2016
A Risk Assessment Tool Incorporating New Biomarkers for Cardiovascular Events in Acute Coronary Syndromes: The Organization to Assess Strategies in Ischemic Syndromes (OASIS) Risk Score. 32:1332-1339. 2016
2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation. 32:1170-1185. 2016
A New, Simplified Measure of Anticoagulation Control With Warfarin: Potential Role in the Direct Oral Anticoagulant Era. 32:1203.e5-1203.e7. 2016
ATRIAL FIBRILLATION OCCURRING TRANSIENTLY WITH STRESS DURING MEDICAL ILLNESS: A SYSTEMATIC REVIEW. 32:S211-S211. 2016
BARRIERS TO PRESCRIBING TICAGRELOR OVER CLOPIDOGREL: A SURVEY OF INTERNAL MEDICINE AND CARDIOLOGY TRAINEES AND STAFF. 32:S115-S115. 2016
CARDIOVASCULAR COMPLICATIONS OF IBRUTINIB: A SYSTEMATIC REVIEW AND META-ANALYSIS. 32:S272-S272. 2016
COMPREHENSIVE METABOLOMIC ANALYSES REVEAL ALTERATIONS IN GLYCEROPHOSPHOLIPID AND SPHINGOLIPID METABOLISM DURING THE PATHOGENESIS AND PROGRESSION OF ATHEROSCLEROSIS. 32:S239-S239. 2016
Cardiac Revascularization: Influential Factors on Choice - A Patient Perspective. 32:S314-S314. 2016
EFFECT OF MOBILE HEALTH INTERVENTIONS ON THE SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS. 32:S278-S278. 2016
EFFICACY AND SAFETY OF INHALED ANESTHETIC FOR POSTOPERATIVE SEDATION DURING MECHANICAL VENTILATION IN ADULT CARDIAC SURGERY PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. 32:S301-S302. 2016
EXAMINING PERCEPTIONS OF BARRIERS TO PATIENT ENGAGEMENT IN CLINICAL RESEARCH AMONG RESEARCH SCIENTISTS IN A CARDIOVASCULAR RESEARCH NETWORK. 32:S136-S136. 2016
From Coronary Care Units to Cardiac Intensive Care Units: Recommendations for Organizational, Staffing, and Educational Transformation. 32:1204-1213. 2016
HIGH PREVALENCE OF MODIFIABLE RISK FACTORS IDENTIFIED IN PHARMACY-BASED SCREENING PROGRAM. 32:S209-S209. 2016
INCIDENCE AND OUTCOMES FOR ACTIONABLE ATRIAL FIBRILLATION IN A TERTIARY ELECTROCARDIOGRAM READING CENTRE. 32:S256-S256. 2016
INVESTIGATING THE MOLECULAR MECHANISMS BY WHICH SEX HORMONES MODULATE BETA CELL HEALTH IN A MODEL OF HYPERGLYCEMIA-INDUCED ATHEROSCLEROSIS. 32:S77-S78. 2016
Is It Time to Systematically Replace Warfarin With a New Oral Anticoagulant for Higher-Risk Patients With Nonvalvular Atrial Fibrillation?. 32:1203.e9-1203.e11. 2016
PHYSICAL INACTIVITY IN VERY YOUNG CHILDREN WITH CONGENITAL HEART DEFECTS CANNOT BE EXPLAINED BY MOTOR DEVELOPMENT, HOSPITALIZATION OR CARDIOPULMONARY BYPASS EXPOSURE. 32:S131-S131. 2016
PREDICTORS OF GUIDELINE APPROPRIATE ANTICOAGULATION IN PATIENTS WITH ATRIAL FIBRILLATION DISCHARGED FROM THE EMERGENCY DEPARTMENT. 32:S244-S244. 2016
PREDICTORS OF PACEMAKER IMPLANTATION AND LONG-TERM PACEMAKER DEPENDENCY POST CARDIAC SURGERY. 32:S141-S142. 2016
QRS DURATION PREDICTS OUTCOME IN A HEART FAILURE POPULATION. 32:S215-S215. 2016
SURGICAL ABLATION OF ATRIAL FIBRILLATION IN 11 COUNTRIES: THE LAAOS III TRIAL. 32:S98-S98. 2016
SURGICAL ATRIAL FIBRILLATION ABLATION: A SYSTEMATIC REVIEW OF RANDOMIZED TRIALS. 32:s97. 2016
THE EFFECT OF GENDER ON SURVIVAL FROM SUDDEN CARDIAC DEATH IN THE YOUNG. 32:S213-S214. 2016
THE PREVALENCE AND IMPACT OF FRAILTY IN ICD AND CRT-D PATIENTS: EARLY RESULTS FROM THE FRAIL-D STUDY. 32:S140-S140. 2016
THE ROLE OF ENDOPLASMIC RETICULUM STRESS AND GLYCOGEN SYNTHASE KINASE-3α/β IN ATHEROSCLEROTIC PROGRESSION AND REGRESSION. 32:S238-S238. 2016
Temporal Patterns and Predictors of Rate vs Rhythm Control in Patients Attending a Multidisciplinary Atrial Fibrillation Clinic. 32:1247.e7-1247.e13. 2016
The Challenge of Values-Elicitation: Understanding How Patients’ Values Guide Decision-making in the Context of Implantable Cardioverter Defibrillators. 32:S313-S313. 2016
VENOUS THROMBOEMBOLISM PROPHYLAXIS ON AN INPATIENT CARDIOLOGY WARD. WHO IS AT RISK OF UNDER TREATMENT?. 32:S304-S304. 2016
Antithrombotic Treatments for Stroke Prevention in Elderly Patients With Nonvalvular Atrial Fibrillation: Drugs and Doses. 32:1108-1116. 2016
Canadian Cardiovascular Society Quality Indicators for Heart Failure. 32:1038.e5-1038.e9. 2016
Novel Oral Anticoagulants and the Risk of Major Hemorrhage in Elderly Patients With Chronic Kidney Disease: A Nested Case-Control Study. 32:986.e17-986.e22. 2016
Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016). 32:S35-S65. 2016
Canadian Cardiovascular Society/Canadian Society of Cardiac Surgeons/Canadian Society for Vascular Surgery Joint Position Statement on Open and Endovascular Surgery for Thoracic Aortic Disease. 32:703-713. 2016
Resident Physicians Choices of Anticoagulation for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation. 32:824-828. 2016
Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. 32:569-588. 2016
Assessment of Dietary Sodium and Potassium in Canadians Using 24-Hour Urinary Collection. 32:319-326. 2016
Left Atrial Appendage Closure for Atrial Fibrillation: A Story Still Being Written. 32:281-282. 2016
Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics. 32:311-318. 2016
The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice. 32:296-310. 2016
ASCENDING AORTIC ELONGATION IS A PREDICTOR OF AORTIC DISSECTION. 32:S113-S114. 2016
Cardiovascular Risk Factors and In-hospital Mortality in Acute Coronary Syndromes: Insights From the Canadian Global Registry of Acute Coronary Events. 31:1455-1461. 2015
AN EVALUATION OF THE INCIDENCE AND PROGNOSIS OF POST CORONARY ARTERY BYPASS GRAFTING MYOCARDIAL INFARCTION ACCORDING TO DIFFERENT DEFINITIONS IN THE CORONARY TRIAL. 31:S161-S161. 2015
AN EVENT DRIVEN MYOCARDIAL INFARCTION DEFINITION USING TROPONINS AFTER CORONARY ARTERY BYPASS SURGERY IN THE CORONARY TRIAL. 31:S161-S162. 2015
AN INVESTIGATION OF A NON-INVASIVE JUGULAR VENOUS PRESSURE POINT OF CARE DEVICE TO DIAGNOSE AND ASSESS HEART FAILURE IN LONG TERM AND PRIMARY CARE: A MIXED METHOD APPROACH. 31:S127-S127. 2015
CHARACTERIZATION OF ARTERIAL STIFFNESS IN PATIENTS WITH POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME AND EHLERS-DANLOS SYNDROME JOINT HYPERMOBILITY SYNDROME TYPE III. 31:S190-S190. 2015
CORE HEART TEAMS: IMPROVING INTERPROFESSIONAL COMMUNICATION FOR HEART FAILURE MANAGEMENT IN LONG-TERM CARE. 31:S274-S274. 2015
ENVIRONMENTAL SCAN OF SELF-IDENTIFIED HEART FAILURE CLINICS IN ONTARIO. 31:S127-S127. 2015
EXAMINING HYPERTENSION RATES, SEVERITY, KNOWLEDGE, AND MODIFIABLE RISK FACTORS IN OLDER ADULTS RESIDING IN ONTARIO SUBSIDISED HOUSING. 31:S50-S50. 2015
EXAMINING THE EFFECTIVENESS OF USER AND EXPERT DRIVEN INTERNET-BASED LIFESTYLE INTERVENTIONS ON HYPERTENSION CONTROL: A RANDOMIZED CONTROLLED TRIAL. 31:S296-S297. 2015
HIGH-VOLTAGE ICD LEAD IMPEDANCES ARE NOT INCREASED BY ROUTINE DEFIBRILLATION TESTING: Results FROM THE SIMPLE STUDY. 31:S234-S235. 2015
INFLAMMATORY AND HEMOSTATIC RESPONSE TO CARDIAC SURGERY WITH CARDIOPULMONARY BYPASS IN CHILDREN: IMPACT OF INTRAOPERATIVE MANAGEMENT. 31:S307-S307. 2015
INNOCENT MURMUR BUT NOT CONGENITAL HEART DEFECT TREATMENT HISTORY IS ASSOCIATED WITH MOTOR SKILL DELAY AMONG TODDLERS SEEN IN A CARDIAC CLINIC. 31:S123-S123. 2015
INTERPROFESSIONAL CARE PROCESSES TO MANAGE RESIDENTS WITH HEART FAILURE IN LONG-TERM CARE. 31:S128-S128. 2015
LONGER LENGTH OF INITIAL PRESCRIPTION POST-STEMI IS ASSOCIATED WITH HIGHER MEDICATION ADHERENCE: A POST-HOC SUB-STUDY OF THE DERLA-STEMI TRIAL. 31:S46-S47. 2015
MATERNAL CARDIOVASCULAR EFFECTS OF PLACENTAL DYSFUNCTION IN THE 2ND TRIMESTER. 31:S55-S55. 2015
PATTERNS OF ANTICOAGULATION PRESCRIPTION FOR PATIENTS WITH ACTIONABLE ATRIAL FIBRILLATION WHO ATTEND THE EMERGENCY DEPARTMENT. 31:S245-S246. 2015
QRS DURATION IN A GENERAL HEART FAILURE POPULATION; NATURAL HISTORY AND IMPACT ON OUTCOMES. 31:S135-S135. 2015
THE ROLE OF ENDOPLASMIC RETICULUM STRESS AND GLYCOGEN SYNTHASE KINASE-3α/β IN ATHEROSCLEROTIC PROGRESSION AND REGRESSION. 31:S112-S113. 2015
THE ROLE OF REGISTERED NURSES AND NURSE PRACTITIONER’S WITHIN HEART FAILURE CLINIC TEAMS IN ONTARIO. 31:S323-S323. 2015
TOO FRAIL FOR AN ICD? THE FRAIL-ICD STUDY: A SYSTEMATIC ASSESSMENT OF FRAILTY IN ELDERLY PATIENTS REFERRED FOR PRIMARY PREVENTION ICDS. 31:S247-S248. 2015
UPDATE ON A NATIONAL SURVEY ON RESIDENT PHYSICIANS ATTITUDES TOWARDS ANTICOAGULATION FOR STROKE PREVENTION IN ATRIAL FIBRILLATION. 31:S263-S264. 2015
Cardiovascular Disease in South Asian Migrants. 31:1139-1150. 2015
The Relationship Between Trimethylamine-N-Oxide and Prevalent Cardiovascular Disease in a Multiethnic Population Living in Canada. 31:1189-1194. 2015
Reply to Xu—Oral Anticoagulants, Health Technology Assessment, and Health Policy. 31:1074.e13-1074.e13. 2015
Spontaneous Coronary Artery Dissection Misdiagnosed as Takotsubo Cardiomyopathy: A Case Series. 31:1073.e5-1073.e8. 2015
Comparison of Dual-antiplatelet Therapy to Mono-antiplatelet Therapy After Transcatheter Aortic Valve Implantation: Systematic Review and Meta-analysis. 31:775-784. 2015
Pericardial Effusions: Do They All Require Pericardiocentesis?. 31:812-815. 2015
The 2015 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. 31:549-568. 2015
The New Dyslipidemia Guidelines: What Is the Debate?. 31:605-612. 2015
Cost Implication of an Early Invasive Strategy on Weekdays and Weekends in Patients With Acute Coronary Syndromes. 31:314-319. 2015
Safety of Urgent Cardioversion for Patients With Recent-Onset Atrial Fibrillation and Flutter. 31:239-241. 2015
The Ethnoepidemiology of Obesity. 31:131-141. 2015
Can Diagnostic and Procedural Skills Required to Practice Cardiology as a Specialist Be Mastered in 3 Years?. 31:91-94. 2015
Effects of Sinus Rhythm Maintenance on Left Heart Function After Electrical Cardioversion of Atrial Fibrillation: Implications for Tachycardia-Induced Cardiomyopathy. 31:36-43. 2015
The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: Anemia, Biomarkers, and Recent Therapeutic Trial Implications. 31:3-16. 2015
The New Canadian Cardiovascular Society Algorithm for Antithrombotic Therapy of Atrial Fibrillation Is Appropriately Based on Current Epidemiologic Data. 31:20-23. 2015
Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology/Canadian Society of Cardiac Surgery Position Statement on Revascularization—Multivessel Coronary Artery Disease. 30:1482-1491. 2014
Electrocardiographic Interpretation Skills of Cardiology Residents: Are They Competent?. 30:1721-1724. 2014
Hypertension Due to Antiangiogenic Cancer Therapy With VEGF Inhibitors: Is Autonomic Nervous System Toxicity Another Possible Mechanism?. 30:1733.e1-1733.e2. 2014
Increased Uptake of Guideline-Recommended Oral Antiplatelet Therapy: Insights from the Canadian Acute Coronary Syndrome Reflective. 30:1725-1731. 2014
Automatic Implantable Cardioverter Defibrillator Lead Dislodgement Resulting in Sudden Cardiac Death: A Case Report. 30:1460.e7-1460.e9. 2014
Long-term Outcome of Unprotected Left Main Stenting: A Canadian Tertiary Care Experience. 30:1407-1414. 2014
VDD vs DDD Pacemakers: A Meta-analysis. 30:1385-1391. 2014
2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation. 30:1114-1130. 2014
A SIMPLE MULTI-COMPONENT INTERVENTION IMPROVES SELF MANAGEMENT IN HEART FAILURE. 30:S201-S201. 2014
Aligning Health Care Policy With Evidence-Based Medicine: The Case for Funding Direct Oral Anticoagulants in Atrial Fibrillation. 30:1245-1248. 2014
Association Between Drug-Eluting Stent Type and Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention. 30:1170-1176. 2014
BLOOD TRANSFUSIONS ARE ASSOCIATED WITH WORSE OUTCOMES AFTER CORONARY ARTERY BYPASS GRAFTING. 30:S160-S161. 2014
CARDIAC-RELATED PRODROMAL SYMPTOMS, ACUTE PAIN AND ANXIETY IN RURAL ACUTE CORONARY SYNDROME PATIENTS. 30:S366-S366. 2014
COAGULATION SYSTEM ABNORMALITIES AND HEPARIN RESPONSE IN CHILDREN UNDERGOING CARDIAC SURGERY. 30:S171-S172. 2014
CONTRIBUTION OF AORTIC REGURGITATION TO LEFT VENTRICLE LOAD IN PATIENTS WITH AORTIC STENOSIS: A MATHEMATICAL MODEL ANALYSIS. 30:S105-S105. 2014
DUAL VERSUS MONO-ANTIPLATELET THERAPY POST-TRANSCATHETER AORTIC VALVE IMPLANTATION: A META-ANALYSIS OF 30-DAY OUTCOMES. 30:S96-S97. 2014
ENGAGING PATIENTS AND FAMILIES DURING DEVELOPMENT OF A PATIENT DECISION AID (PTDA) FOR AN IMPLANTABLE DEFIBRILLATOR - ACCEPTABILITY RESULTS. 30:S365-S366. 2014
GENDER SPECIFIC DIFFERENCES IN A NEW APOE-/-:INS2+/AKITA MOUSE MODEL OF HYPERGLYCEMIA-INDUCED ATHEROSCLEROSIS. 30:S325-S325. 2014
HEART RATE VARIABILITY TRENDS IN PATIENTS RECEIVING A SIX-MONTH COURSE OF BEVACIZUMAB - A CARDIOTOXIC ANTI-CANCER AGENT. 30:S311-S311. 2014
HYPERGLYCAEMIC APOLIPOPROTEIN-E DEFICIENT MICE HAVE ACCELERATED ATHEROSCLEROSIS AND ABERRANT VASA VASORUM NEOVASCULARIZATION. 30:S269-S270. 2014
IMPACT OF THE HEART FAILURE PALLIATIVE APPROACH TO CARE (HEFPAC) IN PRACTICE: A PILOT STUDY. 30:S364-S364. 2014
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR THERAPY RATES IN PATENTS WITH ISCHEMIC CARDIOMYOPATHY SELECTED FOR PRIMARY PREVENTION DEVICES ON THE BASIS OF LEFT VENTRICULAR EJECTION FRACTION AND ELECTROPHYSIOLOGY TESTING. 30:S323-S323. 2014
INTERIM PERFORMANCE METRICS OF AN INNOVATIVE, WEB-BASED CANADIAN JOURNAL OF CARDIOLOGY KNOWLEDGE DISSEMINATION PLATFORM. 30:S315-S315. 2014
Influence of Coronary Anatomy and SYNTAX Score on the Variations in Revascularization Strategies for Patients With Multivessel Disease. 30:1155-1161. 2014
METABOLOMIC INVESTIGATION OF THE HEXOSAMINE BIOSYNTHESIS PATHWAY IN HYPERGLYCEMIA-INDUCED ACCELERATED ATHEROSCLEROSIS. 30:S271-S271. 2014
PKR-LIKE ENDOPLASMIC RETICULUM KINASE (PERK) AND GLYCOGEN SYNTHASE KINASE (GSK)-3α/β SIGNALING REGULATE ATHEROSCLEROSIS DEVELOPMENT. 30:S325-S326. 2014
PREVALENCE OF RHEUMATIC HEART DISEASE IN URBAN AND RURAL ANGOLA BY ECHOCARDIOGRAPHY. 30:s104-s105. 2014
RADIAL VERSUS FEMORAL ACCESS FOR CORONARY ANGIOGRAPHY/INTERVENTION IN WOMEN WITH ACUTE CORONARY SYNDROMES: INSIGHTS FROM THE RIVAL TRIAL. 30:S96-S96. 2014
RATIONALE AND DESIGN OF THE PROGRAM FOR THE IDENTIFICATION OF “ACTIONABLE” ATRIAL FIBRILLATION (PIAAF): SYSTEMATIC IDENTIFICATION TO DETECT PREVIOUSLY UNDIAGNOSED OR UNTREATED AF IN THE COMMUNITY. 30:S290-S290. 2014
RECOGNITION OF ISCHEMIC ELECTROCARDIOGRAPHIC PATTERNS AS MARKERS OF INCREASED RISK IN PATIENTS WITH ACUTE PULMONARY EMBOLISM. 30:S74-S75. 2014
RESIDENT PHYSICIAN ATTITUDES TOWARD ANTICOAGULATION FOR STROKE PREVENTION IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION. 30:S311-S311. 2014
Riociguat: A Novel Therapeutic Option for Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension. 30:1233-1240. 2014
STEMI IN THE ELDERLY: CONTEMPORARY OUTCOMES IN THE ERA OF PRIMARY PERCUTANEOUS CORONARY INTERVENTION. 30:S248-S249. 2014
THE SYMPOMATIC TIPPING POINT: FACTORS THAT PROMPT MEN AND WOMEN TO SEEK MEDICAL CARE. 30:S132-S132. 2014
THERAPEUTIC STRATEGY MULTIVESSEL DISEASE: WHAT WERE THEY THINKING?. 30:S258-S258. 2014
TOWARDS GUIDELINE INFORMED LONG TERM CARE FOR RESIDENTS WITH HEART FAILURE: INFLUENCES ON THE NURSE’S ROLE. 30:S360-S360. 2014
Circulating Levels of Matrix Gla Protein and Progression of Aortic Stenosis: A Substudy of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) Trial. 30:1088-1095. 2014
Canadian Cardiovascular Society Guidelines for the Diagnosis and Management of Stable Ischemic Heart Disease. 30:837-849. 2014
Oral Anticoagulant Use in Patients With Chronic Kidney Disease: How to Choose, and the Importance of Empiric Human Data. 30:853-854. 2014
To Thin or Not to Thin: A Case of Peripartum Cardiomyopathy. 30:835.e1-835.e2. 2014
Traditional Cardiovascular Risk Factors and the Presence of Obstructive Coronary Artery Disease in Men and Women. 30:820-826. 2014
Antihypertensive Drug Prescribing and Persistence Among New Elderly Users: Implications for Persistence Improvement Interventions. 30:647-652. 2014
Greater Mortality Risk Among Patients With Delayed Follow-up After Implantable Cardioverter Defibrillator Procedures. 30:598-605. 2014
Sedation, Analgesia, and Anaesthesia Variability in Laboratory-Based Cardiac Procedures: An International Survey. 30:627-633. 2014
The 2014 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. 30:485-501. 2014
The Population Risks of Dietary Salt Excess Are Exaggerated. 30:507-512. 2014
Are the ACC/AHA Guidelines on the Treatment of Blood Cholesterol a Game Changer? A Perspective From the Canadian Cardiovascular Society Dyslipidemia Panel. 30:377-380. 2014
Left Ventricular Lead Position and Outcomes in the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT). 30:413-419. 2014
Recent Advances in Antidotes for Direct Oral Anticoagulants: Their Arrival Is Imminent. 30:381-384. 2014
The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Rehabilitation and Exercise and Surgical Coronary Revascularization. 30:249-263. 2014
Managing Novel Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Device Surgery: Canadian Survey. 30:231-236. 2014
Predictors of Radial Artery Size in Patients Undergoing Cardiac Catheterization: Insights From the Good Radial Artery Size Prediction (GRASP) Study. 30:211-216. 2014
Characteristics, management and acute outcome of patients admitted following out-of-hospital cardiac arrest. 30:S86-S87. 2014
Changes in Circulating Progenitor Cells Are Associated With Outcome in Heart Failure Patients: A Longitudinal Study. 29:1657-1664. 2013
Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Working Group Consensus Update. 29:1553-1568. 2013
Predictors of Mortality in Patients With an Implantable Cardiac Defibrillator: A Systematic Review and Meta-analysis. 29:1729-1740. 2013
Presentation, Diagnosis, and Medical Management of Heart Failure in Children: Canadian Cardiovascular Society Guidelines. 29:1535-1552. 2013
Canadian Cardiovascular Society Position Statement on Radiation Exposure From Cardiac Imaging and Interventional Procedures. 29:1361-1368. 2013
Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy. 29:1334-1345. 2013
Left Atrial Appendage Occlusion Study II (LAAOS II). 29:1443-1447. 2013
Length of Initial Prescription at Hospital Discharge and Long-term Medication Adherence for Elderly Patients With Coronary Artery Disease: A Population-Level Study. 29:1408-1414. 2013
Acute Detrimental Effects of the Anti-Cancer Agent Bevacizumab on Heart Rate Variability. 29:S332-S333. 2013
Cardiac Energy Metabolism Is Positively Associated With Left Ventricular Function in Physically Active Healthy and Overweight Adolescents. 29:S145-S145. 2013
Does a Perioperative Cardiovascular Service Improve Patient Cardiovascular Outcomes?. 29:S401-S402. 2013
Exploring the Effects of Chronic Remote Ischemic Preconditioning Versus High-Intensity Exercise on Improving Peak Exercise Capacity and Cardiac Energy Metabolism: a Randomized, Crossover Clinical Trial. 29:S338-S338. 2013
Hdl Protects Macrophages Against Apoptosis in a PDZK1-Dependent Manner. 29:S166-S166. 2013
Home Administered Lasix Therapy in Patients With Heart Failure and Chronic Congestion (HALT). 29:S387-S387. 2013
Implementing Cardiovascular Nursing Research in Practice: A Hands-On Workshop. 29:S394-S394. 2013
Remote Ischemic Preconditioning Does Not Affect Cellular Energy Metabolism Measured by 31-Phosphorus Mr Spectroscopy: a Randomized Crossover Trial. 29:S320-S320. 2013
SR-BI and Its Adaptor Protein PDZK1 Are Required for HDL-Mediated Protection Against Doxorubicin Induced Cardiomyocyte Apotosis. 29:S178-S179. 2013
Safety and Efficacy of Dabigatran Compared With Warfarin for Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-analysis. 29:1203-1210. 2013
Self-Care in Heart Failure Index- Do Scores Change Over Time?. 29:S403-S404. 2013
The Effect of Chronic Remote Ischemic Preconditioning on Blood Pressure in Young, Healthy Adults. 29:S321-S322. 2013
The Evolving Role of Stroke Prediction Schemes for Patients With Atrial Fibrillation. 29:1173-1180. 2013
Antiplatelet Therapy and Cardiac Surgery: Review of Recent Evidence and Clinical Implications. 29:1042-1047. 2013
Transcatheter Aortic Valve Implantation in a Patient With Severe Aortic Insufficiency and Minimal Aortic Annular Calcification. 29:1138.e9-1138.e11. 2013
Identification and Management of Patients at Elevated Cardiometabolic Risk in Canadian Primary Care: How Well Are We Doing?. 29:960-968. 2013
Isolated Cardiac Sarcoidosis: Establishing the Diagnosis With Electroanatomic Mapping-Guided Endomyocardial Biopsy. 29:1015.e1-1015.e3. 2013
Western Database of Lipid Variants (WDLV): A Catalogue of Genetic Variants in Monogenic Dyslipidemias. 29:934-939. 2013
Anticoagulation for Atrial Fibrillation: State of the Art and Recommendations for a Quickly Moving Target. 29:S1-S3. 2013
Assessment of Anticoagulation Intensity and Management of Bleeding With Old and New Oral Anticoagulants. 29:S34-S44. 2013
Periprocedural Management of Oral Anticoagulation in Patients With Atrial Fibrillation: Approach in the Era of New Oral Anticoagulants. 29:S54-S59. 2013
Stroke Prevention in Atrial Fibrillation Patients With Chronic Kidney Disease. 29:S71-S78. 2013
Canada's Contribution to Global Research in Cardiovascular Diseases. 29:742-746. 2013
Circulating Proangiogenic Progenitor Cells Independently Predict Functional Capacity in Heart Failure Patients. 29:664-671. 2013
No Increase in Adverse Events During Aliskiren Use Among Ontario Patients Receiving Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers. 29:586-591. 2013
Reducing Blood Pressure With Internet-Based Interventions: A Meta-analysis. 29:613-621. 2013
The 2013 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. 29:528-542. 2013
A Meta-analysis of Randomized Controlled Trials Comparing Percutaneous Coronary Intervention With Medical Therapy in Stable Angina Pectoris. 29:472-482. 2013
Pneumococcal Endocarditis Causing Valve Destruction in the Absence of Vegetations on Transesophageal Echocardiography: A Series of 3 Consecutive Cases. 29:519.e7-519.e9. 2013
2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. 29:151-167. 2013
Bidirectional Ventricular Tachycardia Secondary to Subacute Myocarditis. 29:254.e13-254.e14. 2013
Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Evidence and Patient Selection. 29:182-195. 2013
Pacemaker-Detected Atrial Fibrillation in Patients With Pacemakers: Prevalence, Predictors, and Current Use of Oral Anticoagulation. 29:224-228. 2013
The 2012 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Acute and Chronic Heart Failure. 29:168-181. 2013
The Burden of Atrial Fibrillation on the Hospital Sector in Canada. 29:229-235. 2013
Trifecta or Triple Threat? The Challenge of Post-PCI Management in Patients Receiving Chronic Oral Anticoagulant Therapy. 29:136-138. 2013
Exploring Gene-Environment Relationships in Cardiovascular Disease. 29:37-45. 2013
Genetic Markers of Inflammation and Their Role in Cardiovascular Disease. 29:67-74. 2013
Genetics of Coagulation: What the Cardiologist Needs to Know. 29:75-88. 2013
The Challenge of Timing Surgery in a Complex Case of Endocarditis. 29:126-129. 2013
030 Is Accelerated Atherosclerosis a Microvascular Complication of Diabetes?. 28:S95-S96. 2012
150 The Use of the Influenza Vaccine in Patients With Implantable Cardiac Defibrillators. 28:S146-S147. 2012
539 Characterization of Sudden Cardiac Death Before Age 40 in Ontario. 28:S300-S300. 2012
A Comparison of Lead Placement Through the Subclavian Vein Technique With Fluoroscopy-Guided Axillary Vein Technique for Permanent Pacemaker Insertion. 28:542-546. 2012
Age and Mental Health Predict Early Device-Specific Quality of Life in Patients Receiving Prophylactic Implantable Defibrillators. 28:502-507. 2012
Management and Outcome of Acute Coronary Syndrome Patients in Relation to Prior History of Atrial Fibrillation. 28:443-449. 2012
The 2012 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment of Risk, and Therapy. 28:270-287. 2012
Canadian Cardiovascular Society/Canadian Anesthesiologists' Society/Canadian Heart Rhythm Society Joint Position Statement on the Perioperative Management of Patients With Implanted Pacemakers, Defibrillators, and Neurostimulating Devices. 28:141-151. 2012
Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control. 28:125-136. 2012
Management of Patients With Refractory Angina: Canadian Cardiovascular Society/Canadian Pain Society Joint Guidelines. 28:S20-S41. 2012
Nonischemic Chest Pain Following Successful Percutaneous Coronary Intervention at a Regional Referral Centre in Southern Ontario. 28:S60-S69. 2012
Patients With Coronary Artery Disease Unsuitable for Revascularization: Definition, General Principles, and a Classification. 28:S50-S59. 2012
Persistent Cardiac Pain: A Burgeoning Science Requiring a New Approach. 28:S1-S2. 2012
Women, Cardiac Syndrome X, and Microvascular Heart Disease. 28:S42-S49. 2012
Should Warfarin Be Restarted After Warfarin-Associated Intracranial Hemorrhage?. 28:6-8. 2012
The Cost of Clopidogrel Use in Atrial Fibrillation in the ACTIVE-A Trial. 28:95-101. 2012
Assessment and Management of Acute Coronary Syndromes (ACS): A Canadian Perspective on Current Guideline-Recommended Treatment – Part 1: Non-ST–Segment Elevation ACS. 27:S387-S401. 2011
Assessment and Management of Acute Coronary Syndromes (ACS): A Canadian Perspective on Current Guideline-Recommended Treatment – Part 2: ST-Segment Elevation Myocardial Infarction. 27:S402-S412. 2011
Lipid Lowering on Progression of Mild to Moderate Aortic Stenosis: Meta-analysis of the Randomized Placebo-Controlled Clinical Trials on 2344 Patients. 27:800-808. 2011
Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension: The Toronto Experience. 27:692-697. 2011
Use of Clopidogrel Post-Coronary Artery Bypass Surgery in Canadian Patients With Acute Coronary Syndromes. 27:711-715. 2011
195 Uterine stem cells are recruited to the infarcted myocardium for cardiac regeneration. 27:S130-S131. 2011
414 Thrombus persistence and embolization after pediatric cardiac surgery. 27:S211-S212. 2011
415 Definition, characterization and clinical sequelae of post-thrombotic syndrome in chidlren with congenital heart disease. 27:S212-S212. 2011
Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Proceedings of a Canadian Working Group Consensus Conference. 27:635-662. 2011
Erratam. 27:663-663. 2011
Influenza Myocarditis and Myositis: Case Presentation and Review of the Literature. 27:514-522. 2011
The 2011 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment of Risk, and Therapy. 27:415-433.e2. 2011
The 2011 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Sleep Apnea, Renal Dysfunction, Mechanical Circulatory Support, and Palliative Care. 27:319-338. 2011
The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines. 27:S1-S59. 2011
Cardiometabolic Risk in Canada: A Detailed Analysis and Position Paper by the Cardiometabolic Risk Working Group. 27:e1-e33. 2011
Identification and Management of Cardiometabolic Risk in Canada: A Position Paper by the Cardiometabolic Risk Working Group (Executive Summary). 27:124-131. 2011
Recommendations for the Use of Genetic Testing in the Clinical Evaluation of Inherited Cardiac Arrhythmias Associated with Sudden Cardiac Death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society Joint Position Paper. 27:232-245. 2011
Statin-Associated Rhabdomyolysis: Is There a Dose-Response Relationship?. 27:146-151. 2011
The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines Executive Summary. 27:208-221. 2011
Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Etiology and Initial Investigations. 27:31-37. 2011
Troponin Elevation in Patients With Supraventricular Tachycardia: What Does It Mean?. 27:110-111. 2011
Cardiovascular complications of Salmonella enteritidis infection. 26:e323-e325. 2010
Interprovincial spoke-to-hub transport using the Impella Recover LP 5.0 left ventricular assist device as a bridge to long-term circulatory support. 26:e320-e322. 2010
Referrals in Acute Coronary Events for CARdiac Catheterization: The RACE CAR trial. 26:e290-e296. 2010
CANadian Network and Centre for Trials INternationally (CANNeCTIN): A national network for Canadian-led trials in cardiovascular diseases and diabetes mellitus. 26:353-358. 2010
Right-sided endocarditis secondary to a peritoneovenous shunt. 26:e280-e281. 2010
The impact of social determinants on cardiovascular disease. 26:8C-13C. 2010
Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada. 26:297-302. 2010
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapy. 26:249-258. 2010
Canadian Cardiovascular Society/Canadian Association of Radiologists consensus training standards for cardiac computed tomography. 26:181-184. 2010
The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs. 26:185-202. 2010
Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: Complex congenital cardiac lesions. 26:e98-e117. 2010
Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: Executive summary. 26:143-150. 2010
End-of-life planning in heart failure: It should be the end of the beginning. 26:135-141. 2010
Lipoprotein-associated phospholipase A2: A new therapeutic target. 26:27A-31A. 2010
Electromagnetic interference induced by magnetic resonance imaging. 26:e64-e64. 2010
Long-term outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice: A Canadian experience. 26:e40-e44. 2010
Cardiac Home Education and Support Trial (CHEST): A pilot study. 25:e393-e398. 2009
Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: A position statement of the Canadian Cardiovascular Society. 25:683-689. 2009
Coronary artery bypass graft surgery and primary percutaneous coronary intervention choices in patients with similar coronary anatomy: A computer-based simulation examines the sex gap. 25:649-653. 2009
Mind the gap: Opportunities for improving end-of-life care for patients with advanced heart failure. 25:635-640. 2009
2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations. 25:567-579. 2009
A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial. 25:509-515. 2009
A case of a leaky Dor. 25:488-488. 2009
Effect of angiotensin-converting enzyme inhibition on C-reactive protein levels: The Ramipril C-Reactive pRotein Randomized evaluation (4R) trial results. 25:e236-e240. 2009
Formation of a national network for rapid response to device and lead advisories: The Canadian Heart Rhythm Society Device Advisory Committee. 25:403-405. 2009
Recommendations for advancing the care of Canadians living with refractory angina pectoris: A Canadian Cardiovascular Society position statement. 25:399-401. 2009
A review of the cost of cardiovascular disease. 25:e195-e202. 2009
Para-aortic arch abscess secondary to Staphylococcus aureus pneumonia. 25:233-236. 2009
Endothelin receptor antagonist therapy in congenital heart disease with shunt-associated pulmonary arterial hypertension: A qualitative systematic review. 25:e63-e68. 2009
The ‘what, when, where, who and how?’ of cardiac computed tomography in 2009: Guidelines for the clinician. 25:135-139. 2009
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: Diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. 25:85-105. 2009
Canadian quality indicators for percutaneous coronary interventions. 24:899-903. 2008
Genetic testing for atherosclerosis risk: Inevitability or pipe dream?. 24:851-854. 2008
Comparison of one-year clinical outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice. 24:771-775. 2008
Cost of illness for chronic stable angina patients enrolled in a self-management education trial. 24:759-764. 2008
Warfarin replacements: Mechanisms underlying emerging agents. 24:56C-60C. 2008
Corrected QT interval prolongation after an overdose of escitalopram, morphine, oxycodone, zopiclone and benzodiazepines. 24:S38-S40. 2008
Enhancing hypertension awareness and management in the elderly: Lessons learned from the Airdrie Community Hypertension Awareness and Management Program (A-CHAMP). 24:561-567. 2008
Resting heart rate: A modifiable prognostic indicator of cardiovascular risk and outcomes?. 24:3A-15A. 2008
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure – 2008 update: Best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies. 24:21-40. 2008
Oscillometric measurement of the ankle-brachial index. 24:49-51. 2008
Missed opportunities for the secondary prevention of cardiovascular disease in Canada. 23:1124-1130. 2007
Apical hypertrophic cardiomyopathy with apical aneurysm. 23:1087-1087. 2007
Apical hypertrophic cardiomyopathy with apical aneurysm. 23:1087-1087. 2007
Cost-effectiveness of clopidogrel in acute coronary syndromes in Canada: A long-term analysis based on the CURE trial. 23:1037-1042. 2007
Early mortality from off-pump and on-pump coronary bypass surgery in Canada: A comparison of the STS and the EuroSCORE risk prediction algorithms. 23:879-883. 2007
Preferences of patients with heart failure for prognosis communication. 23:791-796. 2007
Patterns of medical therapy in patients with peripheral artery disease in a tertiary care centre in Canada. 23:357-361. 2007
Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. 23:21-45. 2007
Canadian guidelines for training in adult perioperative transesophageal echocardiography. 22:1015-1027. 2006
Canadian guidelines for training in adult perioperative transesophageal echocardiography. Recommendations of the Cardiovascular Section of the Canadian Anesthesiologists' Society and the Canadian Society of Echocardiography.. 22:1015-1027. 2006
Universal access – but when? Treating the right patient at the right time: Access to electrophysiology services in Canada. 22:741-746. 2006
A cost comparison of off-pump CABG versus on-pump CABG at one-year: The Canadian Off-Pump CABG Registry. 22:699-704. 2006
Stroke prevention in patients with atrial fibrillation: The diagnosis and management of hypertension by specialists. 22:485-488. 2006
Delivery of primary percutaneous coronary intervention for the management of acute ST segment elevation myocardial infarction: Summary of the Cardiac Care Network of Ontario Consensus Report. 22:243-250. 2006
Clinical prognosis, pre-existing conditions and the use of reperfusion therapy for patients with ST segment elevation acute myocardial infarction. 22:131-139. 2006
Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: Diagnosis and management. 22:23-45. 2006
Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: The Heart Outcomes Prevention Evaluation (HOPE)-2 trial. 22:47-53. 2006
Erratum: "Sex differences in outcomes among patients undergoing percutaneous coronary intervention in Canada (Canadian Journal of Cardiology vol. 21 (118C-119C)). 21:1226. 2005
Sex differences in outcomes among patients undergoing percutaneous coronary intervention in Canada (vol 21, pg 118, 2005). 21:1226-1226. 2005
Statin therapy in Canadian patients with hypercholesterolemia: the Canadian Lipid Study -- Observational (CALIPSO).. 21:1187-1193. 2005
The Canadian off-pump coronary artery bypass graft registry: a one-year prospective comparison with on-pump coronary artery bypass grafting.. 21:1175-1181. 2005
Canadian Cardiovascular Society Consensus Conference: peripheral arterial disease - executive summary.. 21:997-1006. 2005
Canadian Cardiovascular Society and Canadian Thoracic Society position statement on pulmonary arterial hypertension.. 21:909-914. 2005
Coronary vasospasm: a case report and review of the literature.. 21:953-957. 2005
Temporal analysis of acute myocardial infarction in Ontario, Canada.. 21:841-845. 2005
Guidelines for the provision of echocardiography in Canada: recommendations of a joint Canadian Cardiovascular Society/Canadian Society of Echocardiography Consensus Panel.. 21:763-780. 2005
Surrogates of surrogates: the story of hypertension and 24 h blood pressure monitoring.. 21:639-642. 2005
Canadian Cardiovascular Society/Canadian Heart Rhythm Society position paper on implantable cardioverter defibrillator use in Canada.. 21 Suppl A:11A-18A. 2005
Digoxin prescribing for heart failure in elderly residents of long-term care facilities.. 21:281-286. 2005
Cardiac troponin I, a possible predictor of survival in patients with stable congestive heart failure.. 21:39-43. 2005
Influence of education and income on atherogenic risk factor profiles among patients hospitalized with acute myocardial infarction. 20:1219-1228. 2004
Surgical management of valvular heart disease 2004.. 20 Suppl E:7E-120E. 2004
Management of heart failure in Canadian long-term care facilities.. 20:963-969. 2004
The clinical relevance of pharmacological blood pressure lowering mechanisms.. 20 Suppl B:83B-88B. 2004
Antifibrinolytics may be cost saving among recent recipients of combined acetylsalicylic acid and clopidogrel who undergo coronary artery bypass graft surgery.. 20:829-830. 2004
Canadian Cardiovascular Society Consensus Conference 2002: Management of heart disease in the elderly patient.. 20 Suppl A:7A-16A. 2004
Prevalence of mitral valve prolapse in ethnic groups.. 20:511-515. 2004
Reverse atrial electrical remodelling following atrial defibrillation as determined by signal-averaged ECG.. 20:311-315. 2004
Tricuspid valve disruption and ventricular septal defect secondary to blunt chest trauma.. 20:231-232. 2004
Use of valve surgery in Canada.. 20:149-154. 2004
Sarcoid heart disease.. 20:89-93. 2004
The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.. 20:31-40. 2004
The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.. 20:41-54. 2004
Increased occurrence of diabetes in people with ischemic cardiovascular disease and general and abdominal obesity.. 19:1387-1391. 2003
Ventricular septal defect secondary to penetrating trauma without pericardial effusion.. 19:1437-1439. 2003
Regional variations in cardiovascular mortality in Canada.. 19:1241-1248. 2003
Blunt and penetrating cardiac trauma: a review.. 19:1054-1059. 2003
An overview of the methods and data used in the CCORT Canadian Cardiovascular Atlas project.. 19:655-663. 2003
Rapid increase in statins newly dispensed to Ontario seniors between 1994 and 2000.. 19:665-669. 2003
Effects of long term cholesterol lowering on coronary atherosclerosis in patient risk factor subgroups: the Simvastatin/enalapril Coronary Atherosclerosis Trial (SCAT).. 19:487-491. 2003
Prognostic use of cardiac troponin T and troponin I in patients with heart failure.. 19:383-386. 2003
The 2002/3 Canadian Cardiovascular Society consensus guideline update for the diagnosis and management of heart failure.. 19:347-356. 2003
Introduction to the Canadian Cardiovascular Outcomes Research Team's (CCORT) Canadian Cardiovascular Atlas project.. 19:225-229. 2003
The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation.. 19:280-284. 2003
CCORT/CCS quality indicators for acute myocardial infarction care.. 19:38-45. 2003
The fate of endothelial function testing: rationale and design of the Firefighters And Their Endothelium (FATE) study.. 19:61-66. 2003
Practical considerations for the use of nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors in hypertension and kidney disease.. 18:1301-1308. 2002
Profile of the cardiovascular specialist physician workforce in Canada.. 18:835-852. 2002
[Survey on the effectiveness of cardiovascular specialists].. 18:831-834. 2002
The 2001 Canadian Hypertension Recommendations--What is new and what is old but still important.. 18:591-603. 2002
The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification.. 18:604-624. 2002
The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy.. 18:625-641. 2002
The 2000 Canadian recommendations for the management of hypertension: part two--diagnosis and assessment of people with high blood pressure.. 17:1249-1263. 2001
The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure.. 17 Suppl E:5E-25E. 2001
Epidemiology of ischemic heart disease in women.. 17 Suppl D:14D-23D. 2001
The endocarditis that was not: an unusual case of heparin-induced thrombocytopenia with unusual complications.. 17:1180-1182. 2001
Atrial myxoma presenting as isolated unilateral blindness: a case report and review of the literature.. 17:898-900. 2001
The 2000 Canadian Hypertension Recommendations: a summary.. 17:535-538. 2001
The 2000 Canadian recommendations for the management of hypertension: Part one--therapy.. 17:543-559. 2001
Use of carotid ultrasound to stratify risk.. 17 Suppl A:22A-25A. 2001
Predicting and explaining cardiac rehabilitation attendance.. 17:291-296. 2001
Previous exposure to Chlamydia pneumoniae, Helicobacter pylori and other infections in Canadian patients with ischemic heart disease.. 17:270-276. 2001
2000 revision of the Canadian Cardiovascular Society 1997 Consensus Conference on the Evaluation and Management of Chronic Ischemic Heart Disease.. 16:1513-1536. 2000
Epidemiology. 16:53-67. 2000
A novel process for updating recommendations for managing hypertension: rationale and methods.. 16:1094-1102. 2000
Beyond the year 2000 in CHD research: current understanding of the cellular mechanism of atherosclerosis.. 16 Suppl D:1D. 2000
Antiarrhythmic therapy for the prevention of sudden cardiac death.. 16 Suppl C:29C-33C. 2000
Prevention of sudden death from ventricular arrhythmia. Epidemiology.. 16 Suppl C:10C-12C. 2000
Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey.. 16:326-330. 2000
Effects of long term resistance training on left ventricular morphology.. 16:35-38. 2000
Re: The Clinical Quality Improvement Network (CQIN) Investigators. Thromboembolic prophylaxis in 3,575 hospitalized patients with atrial fibrillation. 1998;14:695-702.. 16:99. 2000
Cardiovascular diseases and aboriginal peoples.. 15 Suppl G:44G-46G. 1999
Cardiovascular diseases in ethnic groups.. 15 Suppl G:47G-50G. 1999
Preventing cardiovascular diseases in people with diabetes.. 15 Suppl G:65G-68G. 1999
The Canadian Study of Cardiac Transplantation. Atherosclerosis. Investigators of the CASCADE Study.. 15:1337-1344. 1999
Echocardiographically guided pericardiocentesis - the gold standard for the management of pericardial effusion and cardiac tamponade.. 15:1251-1255. 1999
Left ventricular involvement in right ventricular dysplasia/cardiomyopathy.. 15:1239-1247. 1999
Low rates of preventive practices in patients with peripheral vascular disease.. 15:1259-1263. 1999
Effectiveness of nifedipine GITS in combination with atenolol in chronic stable angina.. 15:1103-1109. 1999
Cardiac rehabilitation: the forgotten intervention.. 15:979-985. 1999
A case of thyrotoxicosis and reversible systolic cardiac dysfunction.. 15:811-814. 1999
Low dose dobutamine echocardiography in the assessment of contractile reserve to predict the outcome of valve replacement for chronic aortic regurgitation.. 15:73-79. 1999
Hypercalcemic cardiomyopathy associated with primary hyperparathyroidism mimicking primary obstructive hypertrophic cardiomyopathy.. 14:1397-1400. 1998
Is brain cancer an occupational disease of cardiologists?. 14:1385-1388. 1998
The Study of Health Assessment and Risk in Ethnic groups (SHARE): rationale and design. The SHARE Investigators.. 14:1349-1357. 1998
The study of health assessment and risk in ethnic groups (SHARE): Rationale and design. 14:1349-1357. 1998
Possible adverse skin reaction to carvedilol.. 14:1277-1279. 1998
Beta-blocker therapy for congestive heart failure: a systemic overview and critical appraisal of the published trials.. 14:1045-1053. 1998
ESSENCE trial results: breaking new ground. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events.. 14 Suppl E:15E-19E. 1998
Management of acute coronary syndromes with low molecular weight heparin: TIMI 11A and 11B.. 14 Suppl E:20E-23E. 1998
Changing practice patterns in the management of acute myocardial infarction complicated by cardiogenic shock: elderly compared with younger patients.. 14:923-930. 1998
An open design, multicentre, randomized trial of percutaneous transluminal coronary angioplasty versus stenting, with a heparin-coated stent, of totally occluded coronary arteries: rationale, trial design and baseline patient characteristics. Total Occlusion Study of Canada (TOSCA) Investigators.. 14:825-832. 1998
Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. The Clinical Quality Improvement Network (CQIN) Investigators.. 14:695-702. 1998
Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study.. 13:1166-1174. 1997
Survey of cardiac surgeons' perceptions of the addition of ASA to warfarin for patients with mechanical heart valves.. 13:1162-1165. 1997
Is there a role for antioxidant vitamins in the prevention of cardiovascular diseases? An update on epidemiological and clinical trials data.. 13:957-965. 1997
Antihypertensive effects of perindopril treatment in adult spontaneously hypertensive rats.. 13:831-835. 1997
Reference-based pricing (RBP) of prescription drugs.. 13:689-690. 1997
Rationale and design features of a clinical trial examining the effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT). SCAT Investigators.. 13:591-599. 1997
Quantitative relation of electrocardiographic and angiocardiographic measures of risk in patients with coronary atherosclerosis. Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT) Investigators.. 13:363-369. 1997
Coronary artery disease prevention: better management of dyslipidemias required.. 13:127-128. 1997
Pathophysiology and treatment of cocaine toxicity: implications for the heart and cardiovascular system.. 12:1295-1301. 1996
PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.. 12:1183-1190. 1996
The promise and practice of cardiovascular risk reduction: a disease management perspective. Clinical Quality Improvement Network (CQIN) Investigators.. 12:995-999. 1996
Cardiovascular risk management among 1806 low risk patients in a primary care setting. Clinical Quality Improvement Network (CQIN) Investigators.. 12:797-801. 1996
Cause-specific noncardiac mortality in patients with congestive heart failure--a contemporary Canadian audit. Clinical Quality Improvement Network (CQIN) Investigators.. 12:809-813. 1996
Resistant hypertension: an overview.. 12:822-828. 1996
Right ventricular nerve sheath tumour and patent foramen ovale presenting with transient ischemic attack.. 12:789-791. 1996
Acquired left ventricular to right atrial communication and complete heart block following nonpenetrating cardiac trauma.. 12:349-352. 1996
Trends and variations in the use of vascular surgery in Ontario.. 12:249-253. 1996
The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.. 12:127-137. 1996
[Antithrombotic treatment of atrial fibrillation].. 12 Suppl A:14A-18A. 1996
Antithrombotic therapy in atrial fibrillation.. 12 Suppl A:17A-20A. 1996
Assessing appropriateness of treatment: a case study of transplantation in older patients with congestive heart failure.. 12:47-52. 1996
Collaborative cardiovascular clinical trials in Canada. The Canadian Cardiovascular Collaboration.. 11:649-657. 1995
TREATMENT OF MYOCARDIAL-INFARCTION PATIENTS - CONSENSUS REPORT - REVISION OF THE SCC GUIDELINES FORMULATED IN 1991. 11:659-669. 1995
[Treatment of patients with myocardial infarct: consensus report-- revision of the 1991 guidelines issued by the Canadian Society of Cardiology].. 11:659-669. 1995
Can practice patterns and outcomes be successfully altered? Examples from cardiovascular medicine. The Clinical Quality Improvement Network (CQIN) Investigators.. 11:487-492. 1995
Evaluation of the reproducibility and accuracy of apex beat measurement in the detection of echocardiographic left ventricular dilation.. 11:493-497. 1995
Management of the postmyocardial infarction patient: a consensus report--revision of 1991 CCS guidelines.. 11:477-486. 1995
The consensus report: is it ever the last word?. 11:471. 1995
Hemostasis and atherosclerosis.. 11 Suppl C:29C-34C. 1995
CARDIOVASCULAR TECHNOLOGY SYMPOSIUM. 11:251-252. 1995
[Canadian Consensus Conference on Coronary Thrombolysis--current aspects].. 11:581-586. 1995
Effects of perindopril on hypertension and stroke prevention in experimental animals.. 10 Suppl D:33D-36D. 1994
Enhanced glucose oxidation in exercise-induced myocardial ischemia.. 10:913-919. 1994
Graded exercise testing following thrombolytic therapy for acute myocardial infarction: the importance of timing and infarct location. TPAT Study Group.. 10:897-904. 1994
Canadian Consensus Conference on Coronary Thrombolysis--1994 update.. 10:517-521. 1994
Effects of oxygen free radicals and scavengers on the cardiac extracellular collagen matrix during ischemia-reperfusion.. 10:203-213. 1994
Diagnosis and management of heart failure. Canadian Cardiovascular Society.. 10:613-654. 1994
The changing clinical profile of coronary artery bypass graft patients, 1970-89.. 10:71-76. 1994
Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.. 9:405-412. 1993
Long term clinical outcomes following isolated mitral valve replacement.. 9:417-422. 1993
Thrombolytic therapy in acute pulmonary embolism.. 9:158-159. 1993
In vivo skeletal muscle metabolism during dynamic exercise and recovery: assessment by nuclear magnetic resonance spectroscopy.. 8:819-824. 1992
Resuscitating the cardiology journal club.. 8:520-522. 1992
Right ventricular dysplasia: morphological findings in 13 cases.. 8:261-268. 1992
Atherosclerosis in internal mammary arteries selected for coronary artery bypass grafting.. 8:50-52. 1992
Changes in acute myocardial infarction risk and patterns of practice for patients older and younger than 70 years, 1987-90.. 8:596-600. 1992
Contemporary medical management of left ventricular dysfunction and congestive heart failure.. 8:611-619. 1992
The cost-effectiveness of routine post myocardial infarction exercise stress testing.. 6:157-163. 1990
Rupture of both left ventricular papillary muscles following acute myocardial infarction.. 6:66-70. 1990
Acute myocardial infarction: contemporary risk and management in older versus younger patients.. 6:241-246. 1990
Death following coronary angiography in a young woman with isolated left coronary ostial stenosis.. 5:149-154. 1989
One year mortality outcomes of all coronary and intensive care unit patients with acute myocardial infarction, unstable angina or other chest pain in Hamilton, Ontario, a city of 375,000 people.. 5:239-246. 1989
Transesophageal echocardiography: Experience of a Canadian centre. 5:255-62. 1989
Acute chest pain in an elderly woman.. 4:144-145. 1988
Coronary care unit utilization in Hamilton, Ontario, a city of 375,000 people.. 4:25-32. 1988
Primary pulmonary artery sarcoma mimicking pulmonary thromboembolism.. 4:393-396. 1988
Anasarca due to pulmonic valve regurgitation with low pulmonary vascular resistance.. 3:162-163. 1987
Inability of caliper measurement to enhance observer agreement in the interpretation of coronary cineangiograms.. 1:24-29. 1985
COMPREHENSIVE METABOLOMIC ANALYSIS OF DIABETIC ATHEROSCLEROSIS 2015

Canadian Journal of Cardiology Journal

Overview

publication venue for

has subject area

Identity

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)